{"gene":"SLC2A1","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":1985,"finding":"The primary structure of human GLUT1 (SLC2A1) was deduced from cDNA sequencing, revealing a ~500 amino acid protein with 12 predicted membrane-spanning domains, with the amino terminus, carboxyl terminus, and a central hydrophilic domain all predicted to lie on the cytoplasmic face.","method":"cDNA cloning and sequencing, structural analysis by fast atom bombardment mapping and gas phase Edman degradation of purified erythrocyte transporter","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — original sequence determination with biochemical validation, foundational paper replicated extensively","pmids":["3839598"],"is_preprint":false},{"year":1987,"finding":"The human GLUT1 gene (designated GLUT) was mapped to chromosome 1p31.3–p35 (most likely 1p33), and a two-allele XbaI restriction-fragment-length polymorphism was identified.","method":"Somatic cell hybrid panel hybridization and in situ hybridization to metaphase chromosomes","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — direct chromosomal mapping with two orthogonal methods","pmids":["3028891"],"is_preprint":false},{"year":1990,"finding":"GLUT1 is selectively and highly expressed at the blood-brain barrier (cerebral capillary endothelium); essentially 100% of glucose transporter binding sites at the BBB can be accounted for by the GLUT1 isoform.","method":"Quantitative Western blotting with purified erythrocyte GLUT1 standard, [3H]cytochalasin B binding assay, and in situ hybridization on bovine brain cortex","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal quantitative methods in a single study, widely replicated","pmids":["2211679"],"is_preprint":false},{"year":1991,"finding":"GLUT1 deficiency syndrome was established as a disease caused by defective glucose transport across the blood-brain barrier, resulting in persistent hypoglycorrhachia, seizures, and developmental delay.","method":"Clinical characterization combined with erythrocyte glucose transport assays and CSF glucose measurements","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 2 — functional transport assays linked to clinical phenotype, landmark disease-defining paper","pmids":["1714544"],"is_preprint":false},{"year":1991,"finding":"GLUT1 expression is regulated as a stress-response gene: glucose starvation, calcium ionophore A23187, 2-mercaptoethanol, and tunicamycin all increase GLUT1 mRNA (50–300%) similarly to GRP-78, classifying GLUT1 as a member of the glucose-regulated protein (GRP) family of stress proteins.","method":"Northern blot analysis of GLUT1 and GRP-78 mRNA in L8 myocytes and NIH 3T3 fibroblasts under multiple stress conditions; glucose uptake assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal stress stimuli, two cell lines, replicated across conditions","pmids":["1706526"],"is_preprint":false},{"year":1991,"finding":"Glucose deprivation induces selective accumulation of glycosylated GLUT1 (55 kDa) in the plasma membrane of NRK cells, increasing hexose transport; under glucose-fed conditions GLUT1 resides predominantly in intracellular membrane fractions.","method":"Subcellular fractionation, [3H]cytochalasin B binding, immunofluorescence microscopy, Western blotting","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization methods in a single study","pmids":["2017192"],"is_preprint":false},{"year":1992,"finding":"Glucose autoregulates its own transport in L8 myocytes by modulating GLUT1 trafficking: decreased glucose concentration increases plasma membrane GLUT1 and transport activity with parallel reductions in intracellular GLUT1, without apparent changes in intrinsic transporter activity.","method":"[3H]cytochalasin B binding, Western blotting of subcellular fractions, 2-deoxy-D-[3H]glucose uptake assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — quantitative subcellular fractionation combined with functional transport assays","pmids":["1520263"],"is_preprint":false},{"year":1993,"finding":"Inhibition of oxidative phosphorylation (azide treatment) causes rapid ~7.5-fold stimulation of GLUT1-mediated glucose transport in Clone 9 cells primarily through activation of pre-existing plasma membrane GLUT1, not translocation from intracellular pools.","method":"Immunofluorescence microscopy, differential centrifugation + Western blot, cell surface biotinylation, [3H]cytochalasin B binding","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — four independent orthogonal approaches reaching consistent conclusion","pmids":["8349608"],"is_preprint":false},{"year":1993,"finding":"GLUT1 topology was experimentally determined: the protein contains 12 membrane-spanning domains with cytoplasmic N- and C-termini and a large central cytoplasmic loop, consistent with the predicted model; insertion of an exofacial epitope into various loops confirmed this topology in vivo.","method":"Glycosylation scanning mutagenesis expressed in Xenopus oocytes (in vivo) and rabbit reticulocyte lysate (in vitro); 2-deoxyglucose uptake assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with functional readout in two expression systems","pmids":["8051147"],"is_preprint":false},{"year":1993,"finding":"Transfection of GLUT1 (but not GLUT2) into AtT-20ins cells increases glucose transport affinity (Km ~4 mM vs 2 mM for untransfected cells) but does not confer glucose-stimulated insulin release, demonstrating that GLUT1 kinetics are insufficient to act as a glucose sensor in beta-cells.","method":"Stable transfection, 3-O-methyl glucose uptake kinetics, static incubation and perifusion insulin secretion assays, [5-3H]glucose usage","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — detailed kinetic analysis with functional insulin secretion readout","pmids":["8325893"],"is_preprint":false},{"year":1993,"finding":"During glucose deprivation of 3T3-L1 adipocytes, a lower molecular weight (37 kDa) underglycosylated isoform of GLUT1 appears; the 10-fold increase in transport activity requires new protein synthesis but involves only a small transient increase in GLUT1 mRNA, suggesting post-translational regulation and trafficking changes dominate.","method":"Glucose transport assays, Northern blot, Western blot with glycoforms, mannose/analog competition experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical approaches but mechanism of transport increase not fully resolved","pmids":["7678253"],"is_preprint":false},{"year":1994,"finding":"GLUT1 topology confirmed in vivo as 12 transmembrane helices; insertion into the NH2 terminus, large central loop, or exofacial loops 2, 3, and 5 had little effect on transport activity, whereas insertion into other soluble domains abolished or significantly reduced transport.","method":"Glycosylation scanning mutagenesis in Xenopus oocytes with 2-deoxyglucose uptake functional readout","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with functional validation","pmids":["8051147"],"is_preprint":false},{"year":1995,"finding":"Exposure to calcium ionophore A-23187 stimulates GLUT1 gene expression via both enhanced transcription (1.5–1.7-fold by nuclear run-on) and mRNA stabilization (half-life increased from 1.5 h to 5.5 h), resulting in increased GLUT1 protein and glucose transport.","method":"Nuclear run-on transcription assays, actinomycin D mRNA decay experiments, Northern blot, Western blot, 3-O-methyl-D-glucose transport assays","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 1–2 — nuclear run-on plus mRNA stability assays, multiple orthogonal methods","pmids":["7491913"],"is_preprint":false},{"year":1996,"finding":"GLUT1 interacts with the ER chaperones calnexin and calreticulin in a glycosylation-dependent manner; non-glycosylated GLUT1 mutants fail to associate with either chaperone, indicating that the N-linked oligosaccharide is essential for this interaction during GLUT1 folding in the ER.","method":"Cross-linking studies, co-immunoprecipitation with anti-calnexin antibody, in vitro translation in the presence of microsomal membranes using a truncated GLUT1 construct","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — co-IP with mutagenesis control (aglycosyl mutant) and UV crosslinking","pmids":["8662691"],"is_preprint":false},{"year":1996,"finding":"Increased cytosolic calcium does not mediate the induction of GLUT1 mRNA in response to inhibition of oxidative phosphorylation by azide; although ionomycin raises [Ca2+]i and induces GLUT1 mRNA, BAPTA chelation of Ca2+ does not prevent azide-induced GLUT1 mRNA induction, demonstrating distinct signaling pathways.","method":"BAPTA chelation, ionomycin dose-response, ionomycin vs. azide kinetic comparisons, [Ca2+]i measurements, actinomycin D mRNA decay, Northern blot","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — five lines of experimental evidence with Ca2+ manipulation and mRNA kinetics","pmids":["8772449"],"is_preprint":false},{"year":1996,"finding":"Glycogen in 3T3-L1 adipocytes serves as a carbohydrate buffer for GLUT1 glycosylation during glucose deprivation; glycogen-depleted cells show more rapid alteration of GLUT1 glycosylation upon glucose removal, linking cellular glycogen stores to GLUT1 glycosylation fidelity.","method":"Glycogen quantification, glycogen depletion experiments, glycoform analysis by Western blot comparing adipocytes vs. CHO cells","journal":"The American journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical and cell biological approach, single lab","pmids":["8928771"],"is_preprint":false},{"year":1996,"finding":"Both thyroid hormone (T3) and insulin stimulate glucose transport in Clone 9 cells (which express only GLUT1) primarily through activation of plasma membrane-resident GLUT1, not solely by increasing surface GLUT1 abundance, as transport stimulation exceeds the increase in surface GLUT1 detected by biotinylation.","method":"Cell surface biotinylation, Western blot of plasma membrane fractions, 3-O-methyl-D-glucose transport assays","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative surface labeling plus functional assay, single lab","pmids":["8972727"],"is_preprint":false},{"year":1997,"finding":"GLUT1 and GLUT3 transport dehydroascorbic acid (DHA) with apparent Km values of 1.1 mM and 1.7 mM, respectively; DHA transport is inhibited by glucose analogs and cytochalasin B but not by L-glucose or fructose; GLUT2, GLUT5, and SGLT1 do not transport DHA; none transport ascorbic acid.","method":"Xenopus laevis oocyte expression system, radiolabeled sugar uptake, HPLC confirmation of intracellular reduction of DHA to AA, CHO cell overexpression, competition assays with inhibitors","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in Xenopus oocytes with multiple orthogonal validations (HPLC, CHO overexpression, inhibitor pharmacology, mutagenesis)","pmids":["9228080"],"is_preprint":false},{"year":1997,"finding":"The C-terminal tail of GLUT2 contributes to glucose transport kinetics (Km for 2-deoxyglucose), while the N-terminal region of GLUT1/GLUT2 determines substrate specificity for alternative substrates (fructose, arabinose, streptozotocin); structural domains for substrate specificity are distinct from those governing kinetic function.","method":"GLUT1/GLUT2 chimeras and N62Q mutant expressed via recombinant adenovirus in CV-1 cells; 2-deoxyglucose Km/Vmax kinetics; fructose, arabinose, streptozotocin uptake assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — chimeric mutagenesis with functional kinetic analysis, multiple substrate specificity assays","pmids":["9154929"],"is_preprint":false},{"year":1999,"finding":"Sp1 binds to the −102/−82 region of the GLUT1 promoter during fetal cardiac development but not during adulthood; Sp1 site mutation abolishes high transcriptional activity in cardiomyocytes; Sp1 is downregulated postnatally in heart and skeletal muscle, establishing Sp1 as a key transcriptional activator of GLUT1 in the perinatal heart.","method":"Transient transfection assays (reporter gene), electrophoretic mobility shift assays (EMSA), site-directed mutagenesis of Sp1 binding site, Western blot of Sp1 in heart/muscle development","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — EMSA plus mutagenesis plus reporter assay, mechanistic identification of transcription factor binding site","pmids":["10364200"],"is_preprint":false},{"year":2000,"finding":"Fifteen novel heterozygous GLUT1 mutations (including large deletion, missense, nonsense, deletions, insertions, and splice site mutations) cause GLUT1 deficiency syndrome; these mutations correlate with hypoglycorrhachia and reduced erythrocyte glucose transport activity.","method":"FISH, PCR, SSCP, DNA sequencing; erythrocyte glucose transport functional assay","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 — systematic mutation identification combined with functional transport assays in a large patient cohort","pmids":["10980529"],"is_preprint":false},{"year":2001,"finding":"Overexpression of stomatin reduces basal GLUT1-mediated glucose transport by 35–50% without altering plasma membrane GLUT1 content, through protein–protein interaction; stomatin binds specifically to the C-terminal 42-amino acid segment of GLUT1 but not to its central loop, decreasing intrinsic transporter activity.","method":"Stable transfection of stomatin, glucose transport assays, co-immunoprecipitation, GST-fusion protein pulldown with GLUT1 C-terminal and central loop domains, Western blot of plasma membrane fractions","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1–2 — co-IP plus GST pulldown domain mapping plus functional transport assay, identifies specific binding region","pmids":["11287341"],"is_preprint":false},{"year":2001,"finding":"Hyperosmolarity stimulates GLUT1 expression in a biphasic manner: early phase (0–6 h) involves activation of pre-existing plasma membrane GLUT1 without change in GLUT1 mRNA/protein; late phase (12–24 h) involves ~7.5-fold increase in GLUT1 mRNA mediated by both enhanced transcription and mRNA stabilization (t½ increased from 2 to 8 h), requiring a 44-bp proximal promoter element.","method":"Glucose transport assays, Northern blot with actinomycin D mRNA half-life measurements, promoter deletion analysis by transient transfection, GLUT1 protein quantification","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1–2 — mechanistic dissection with promoter mapping, mRNA stability, and functional transport assays","pmids":["11546675"],"is_preprint":false},{"year":2001,"finding":"A GLUT1 R126H missense mutation causes autosomal dominant GLUT1 deficiency syndrome; in Xenopus oocyte expression, the mutant shows high membrane expression but significantly reduced Vmax for 3-O-methyl-D-glucose and dehydroascorbic acid transport, demonstrating that R126 is critical for transport function.","method":"Xenopus oocyte expression and transport kinetics, SSCP/sequencing of family members, erythrocyte glucose transport, immunoblot","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1 — in vivo expression system with kinetic analysis demonstrates pathogenicity at molecular level","pmids":["11603379"],"is_preprint":false},{"year":2003,"finding":"GLUT1 serves as a receptor for both HTLV-1 and HTLV-2; HTLV envelope receptor-binding domains inhibit glucose transport by interacting with GLUT1; HTLV infection is selectively blocked by cytochalasin B, GLUT1 siRNA knockdown, or competing HTLV envelope glycoproteins; ectopic GLUT1 (but not GLUT3) rescues infection in GLUT1-depleted cells.","method":"siRNA knockdown, ectopic expression of GLUT1/GLUT3, cytochalasin B inhibition, HTLV infection assays, glucose transport inhibition assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (siRNA, ectopic expression, pharmacological inhibition), specific GLUT1 requirement demonstrated","pmids":["14622599"],"is_preprint":false},{"year":2003,"finding":"N-glycosylation of GLUT1 at its sole N-linked glycosylation site contributes to transporter affinity for glucose: tunicamycin treatment produces a 2–2.5-fold decrease in Km without change in Vmax, and inhibition of N-glycan processing (deoxymannojirimycin, swainsonine) does not affect GLUT1 trafficking or activity in thyroid anaplastic carcinoma cells; O-glycosylation also contributes to transport activity.","method":"Tunicamycin, deoxymannojirimycin, swainsonine inhibitor studies; 2-deoxyglucose uptake; Western blot of glycoforms; jacalin lectin binding; benzyl-GalNAc O-glycosylation inhibition","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibition of glycosylation steps with functional readout, single lab","pmids":["12667615"],"is_preprint":false},{"year":2006,"finding":"Targeted disruption of the promoter and exon 1 of mouse Glut1 in heterozygous mice recapitulates GLUT1 deficiency syndrome: GLUT1+/- mice show epileptiform EEG discharges, impaired motor activity, hypoglycorrhachia, microencephaly, decreased brain glucose uptake (by PET), and 66% reduction of brain GLUT1 protein.","method":"Targeted gene disruption, EEG, PET brain glucose uptake, Western blot, behavioral testing","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — in vivo haploinsufficiency model with multiple phenotypic readouts, functional brain imaging","pmids":["16497725"],"is_preprint":false},{"year":2009,"finding":"A C-terminal PDZ-binding motif in GLUT1 is critical for growth factor-stimulated cell surface localization and protection from lysosomal degradation; disruption of this motif reduces surface GLUT1 and promotes lysosomal targeting; the PDZ-domain protein GIPC binds GLUT1 via this motif and is required for normal GLUT1 surface levels and glucose uptake.","method":"PDZ-motif deletion and point mutation, flow cytometry for surface GLUT1, lysosomal inhibitor experiments, co-immunoprecipitation of GIPC-GLUT1, transferrin receptor recycling comparison, glucose uptake assays in GIPC-deficient cells","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis plus co-IP plus functional trafficking assays, multiple mechanistic readouts","pmids":["19016655"],"is_preprint":false},{"year":2011,"finding":"GLUT1 deficiency syndrome-causing mutations in SLC2A1 can produce both loss of glucose transport and a novel cation leak phenotype in erythrocytes (stomatin-deficient cryohydrocytosis), as demonstrated by Xenopus oocyte expression studies of two specific missense mutations.","method":"Xenopus oocyte expression, glucose transport assays, cation flux measurements, 3D structural modeling of GLUT1","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in Xenopus oocytes showing dual functional defects","pmids":["21791420"],"is_preprint":false},{"year":2011,"finding":"Effector CD4+ T cells (Th1, Th2, Th17) express high surface GLUT1 and are highly glycolytic, while regulatory T cells express low GLUT1 and rely on lipid oxidation; GLUT1 transgenic mice show selective increase in effector T cells; these distinct metabolic programs can be manipulated in vivo to control T cell subset development.","method":"Flow cytometry for surface GLUT1, metabolic flux analysis, GLUT1 transgenic mice, AMPK activator treatment in asthma model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic model plus metabolic profiling plus pharmacological manipulation","pmids":["21317389"],"is_preprint":false},{"year":2013,"finding":"ATM phosphorylates GLUT1 at serine 490 (S490); ATM inhibition decreases surface GLUT1, glucose and DHA transport, and GLUT1 association with GIPC1, while ATM activation (doxorubicin) increases these parameters; S490A mutation phenocopies ATM inhibition and S490D mutation phenocopies ATM activation, establishing S490 as a functional phosphorylation site regulating GLUT1 trafficking.","method":"ATM inhibitor (KU55933) and activator (doxorubicin) experiments, S490A/D point mutants, cell surface GLUT1 quantification, 2-deoxyglucose and DHA transport assays, co-immunoprecipitation of GLUT1/GIPC1, ex vivo skeletal muscle transport","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — phospho-mimetic and phospho-null mutagenesis with functional readouts, in vivo confirmation in skeletal muscle","pmids":["23776597"],"is_preprint":false},{"year":2013,"finding":"TXNIP suppresses glucose uptake by directly binding to GLUT1 and inducing GLUT1 internalization through clathrin-coated pits; AMPK-dependent phosphorylation of TXNIP leads to its rapid degradation, releasing GLUT1 inhibition and acutely increasing GLUT1-mediated glucose influx; long-term adaptation also involves TXNIP-dependent regulation of GLUT1 mRNA levels.","method":"Co-immunoprecipitation of TXNIP-GLUT1, clathrin-coated pit inhibition, AMPK activation/inhibition, TXNIP phosphorylation mutants, glucose uptake assays, GLUT1 surface quantification, mRNA measurements","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — direct binding by co-IP, clathrin pathway inhibitor experiments, AMPK-TXNIP phosphorylation mechanistic link, multiple readouts","pmids":["23453806"],"is_preprint":false},{"year":2013,"finding":"The SNX27-retromer complex maintains GLUT1 surface levels by recycling internalized GLUT1 from endosomes back to the plasma membrane, preventing lysosomal degradation; SNX27 or retromer suppression reduces surface GLUT1 abundance.","method":"Quantitative proteomics of SNX27 interactome, quantification of surface proteome in SNX27/retromer-suppressed cells by quantitative mass spectrometry, direct PDZ domain-VPS26 interaction characterization","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — global quantitative proteomics of interactome combined with surface proteome quantification, mechanistic interaction mapping","pmids":["23563491"],"is_preprint":false},{"year":2014,"finding":"The crystal structure of human GLUT1 was determined at 3.2 Å resolution; the protein adopts a canonical major facilitator superfamily fold captured in an inward-open conformation with 12 transmembrane helices; structural comparison with the bacterial homologue XylE enabled mechanistic interpretation of the alternating access transport mechanism and mapping of disease-associated mutations.","method":"X-ray crystallography at 3.2 Å resolution, structure-based mutagenesis analysis, structural comparison with XylE","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — atomic resolution crystal structure with functional mutagenesis analysis, foundational structural paper","pmids":["24847886"],"is_preprint":false},{"year":2015,"finding":"RdCVF (rod-derived cone viability factor) promotes cone survival by binding to Basigin-1 (BSG1), which then associates with GLUT1, resulting in increased glucose entry into cones and stimulation of aerobic glycolysis; a missense mutation abolishing RdCVF–BSG1 binding prevents glucose uptake stimulation and cone protection.","method":"Co-immunoprecipitation of RdCVF-BSG1 and BSG1-GLUT1, glucose uptake assays, RdCVF missense mutant, in vivo retinitis pigmentosa model, cone survival quantification","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — co-IP of ternary complex, functional glucose uptake assays, disease mutant validation, in vivo photoreceptor survival readout","pmids":["25957687"],"is_preprint":false},{"year":2019,"finding":"Myeloid-specific GLUT1 deletion in mice abolishes glucose uptake and reduces glycolysis and pentose phosphate pathway activity in macrophages; GLUT1-deficient macrophages show reduced phagocytic capacity contributing to unstable atherosclerotic lesion formation in Ldlr-/- mice, while compensatory glutamine and oleate oxidation occurs but maximal respiratory capacity is blunted.","method":"Myeloid-specific Slc2a1 conditional knockout, bone marrow-derived macrophage glucose uptake assays, extracellular flux analysis, flow cytometry for activation markers, phagocytosis assays, atherosclerosis model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — cell-type specific KO with multiple metabolic and functional readouts, in vivo disease model","pmids":["30659108"],"is_preprint":false},{"year":2022,"finding":"RAB21 regulates retromer-mediated recycling of GLUT1/SLC2A1; RAB21 depletion mis-sorts GLUT1 to lysosomes, reduces glucose uptake, and activates AMPK-ULK1 autophagy; RAB21 controls fission of retromer-decorated SNX27-containing endosomal tubules, selectively affecting GLUT1 recycling without overtly disrupting retrograde transport of IGF2R or WLS.","method":"RAB21 siRNA/shRNA depletion, GLUT1 subcellular localization by imaging, glucose uptake assays, AMPK-ULK1 pathway analysis, autophagic flux measurement, retromer complex localization, in vivo tumor growth assays","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — genetic depletion with mechanistic pathway analysis, functional glucose uptake and autophagy readouts, in vivo validation","pmids":["35993307"],"is_preprint":false}],"current_model":"SLC2A1/GLUT1 is a 12-transmembrane-domain major facilitator superfamily uniporter (crystal structure resolved at 3.2 Å in an inward-open conformation) that mediates facilitated diffusion of glucose and dehydroascorbic acid across the plasma membrane; its surface abundance and intrinsic activity are regulated by multiple mechanisms including: TXNIP-induced clathrin-mediated internalization (released by AMPK-dependent TXNIP degradation), retromer/SNX27-RAB21-mediated endosomal recycling, stomatin-mediated inhibition of intrinsic activity via C-terminal interaction, ATM-dependent S490 phosphorylation promoting GIPC1-assisted trafficking to the cell surface, GIPC1 PDZ-binding at the C-terminal motif protecting internalized GLUT1 from lysosomal degradation, and transcriptional activation by Sp1; GLUT1 also acts as the receptor for HTLV-1/2 and is the primary glucose transporter at the blood-brain barrier whose haploinsufficiency causes GLUT1 deficiency syndrome."},"narrative":{"teleology":[{"year":1985,"claim":"Determination of the full primary structure of human GLUT1 from cDNA sequencing established the protein as a ~500 amino acid, 12-transmembrane-domain transporter, providing the molecular framework for all subsequent functional studies.","evidence":"cDNA cloning/sequencing with biochemical validation of purified erythrocyte transporter","pmids":["3839598"],"confidence":"High","gaps":["No three-dimensional structure available","Transport mechanism inferred from topology only","Post-translational regulation unknown"]},{"year":1990,"claim":"Quantitative protein and ligand-binding analyses demonstrated that GLUT1 accounts for essentially all glucose transporter activity at the blood–brain barrier, establishing its physiological centrality for cerebral glucose supply.","evidence":"Quantitative Western blotting, [3H]cytochalasin B binding, and in situ hybridization on bovine brain cortex","pmids":["2211679"],"confidence":"High","gaps":["Contribution of other GLUT isoforms under pathological conditions not addressed","Human BBB confirmation needed"]},{"year":1991,"claim":"Clinical and functional characterization of patients with persistent hypoglycorrhachia, seizures, and developmental delay linked these phenotypes to defective erythrocyte glucose transport, defining GLUT1 deficiency syndrome as a haploinsufficiency disorder.","evidence":"Clinical phenotyping combined with erythrocyte glucose transport assays and CSF glucose measurements","pmids":["1714544"],"confidence":"High","gaps":["Causative mutations not yet molecularly identified at the DNA level in this initial report","Genotype–phenotype correlations not established"]},{"year":1991,"claim":"Discovery that glucose deprivation redistributes GLUT1 from intracellular pools to the plasma membrane, and that GLUT1 mRNA is stress-inducible (like GRP-78), established that GLUT1 surface abundance and expression are dynamically regulated by metabolic stress rather than being constitutive.","evidence":"Subcellular fractionation, immunofluorescence, Northern blots under glucose deprivation, calcium ionophore, tunicamycin, and reductant stress in multiple cell lines","pmids":["1706526","2017192"],"confidence":"High","gaps":["Signaling pathways mediating stress-induced translocation unknown","Whether intrinsic activity also changes during stress not resolved"]},{"year":1993,"claim":"Glycosylation scanning mutagenesis in Xenopus oocytes experimentally verified the 12-transmembrane-helix topology with cytoplasmic N- and C-termini and a large central cytoplasmic loop, resolving the membrane orientation predicted from the sequence.","evidence":"Systematic glycosylation site insertion mutagenesis in Xenopus oocytes and reticulocyte lysate with 2-deoxyglucose uptake readout","pmids":["8051147"],"confidence":"High","gaps":["No atomic-resolution structure","Helix packing and substrate translocation path unknown"]},{"year":1993,"claim":"Inhibition of oxidative phosphorylation was shown to stimulate glucose transport primarily by activating pre-existing plasma membrane GLUT1 rather than recruiting intracellular transporters, revealing that intrinsic transporter activity is a regulated parameter distinct from surface abundance.","evidence":"Four orthogonal approaches (immunofluorescence, differential centrifugation, surface biotinylation, cytochalasin B binding) in Clone 9 cells treated with azide","pmids":["8349608"],"confidence":"High","gaps":["Molecular basis of intrinsic activity modulation unknown","Kinase or signaling intermediate responsible not identified"]},{"year":1997,"claim":"Reconstitution in Xenopus oocytes demonstrated that GLUT1 transports dehydroascorbic acid (Km ~1.1 mM) via the same pathway as glucose, expanding the substrate repertoire beyond hexoses and establishing GLUT1 as the molecular basis for cellular vitamin C acquisition via its oxidized form.","evidence":"Xenopus oocyte expression, radiolabeled uptake, HPLC product identification, CHO overexpression, inhibitor competition","pmids":["9228080"],"confidence":"High","gaps":["Structural basis for DHA recognition versus glucose not defined","Physiological relevance of DHA transport versus sodium-dependent ascorbate transporters not quantified in vivo"]},{"year":1999,"claim":"Identification of Sp1 binding to the −102/−82 promoter element, with postnatal Sp1 downregulation in heart, provided the first transcription-factor-level explanation for the developmental switch from high to low GLUT1 expression in cardiac and skeletal muscle.","evidence":"EMSA, site-directed mutagenesis of Sp1 site, reporter assays, Western blot of Sp1 during heart development","pmids":["10364200"],"confidence":"High","gaps":["Other transcription factors contributing to developmental regulation not mapped","Mechanism of postnatal Sp1 downregulation unknown"]},{"year":2001,"claim":"Stomatin was identified as a direct negative regulator of GLUT1 intrinsic activity that binds the C-terminal 42-amino-acid segment without altering surface expression, providing a molecular mechanism for modulation of transport kinetics independent of trafficking.","evidence":"Co-immunoprecipitation, GST pulldown domain mapping, functional glucose transport in stomatin-overexpressing cells","pmids":["11287341"],"confidence":"High","gaps":["Stoichiometry and structural basis of the stomatin–GLUT1 interaction unknown","Physiological contexts where stomatin regulation is rate-limiting not defined"]},{"year":2003,"claim":"GLUT1 was established as the receptor for HTLV-1 and HTLV-2 through siRNA knockdown, ectopic rescue, and pharmacological inhibition, linking glucose transporter biology to retroviral entry and explaining HTLV tropism.","evidence":"siRNA knockdown, GLUT1/GLUT3 ectopic expression, cytochalasin B inhibition, HTLV infection assays","pmids":["14622599"],"confidence":"High","gaps":["Structural interface between HTLV envelope and GLUT1 not defined","Whether HTLV binding alters glucose transport in infected cells in vivo not resolved"]},{"year":2009,"claim":"Discovery that a C-terminal PDZ-binding motif recruits GIPC1 to protect internalized GLUT1 from lysosomal degradation, and that disruption of this motif reduces surface GLUT1, established the first post-endocytic sorting mechanism controlling GLUT1 fate.","evidence":"PDZ motif deletion/mutation, co-immunoprecipitation of GIPC–GLUT1, surface GLUT1 quantification, lysosomal inhibitor rescue, glucose uptake in GIPC-deficient cells","pmids":["19016655"],"confidence":"High","gaps":["Upstream signals controlling GIPC–GLUT1 interaction not defined","Relationship to retromer-mediated recycling not yet established"]},{"year":2013,"claim":"Three converging studies defined the GLUT1 surface-abundance regulatory circuit: TXNIP directly binds GLUT1 and promotes clathrin-mediated internalization (relieved by AMPK-dependent TXNIP phosphorylation/degradation); ATM phosphorylates GLUT1-S490 to promote GIPC1 binding and surface retention; and SNX27–retromer recycles internalized GLUT1 from endosomes, preventing lysosomal degradation.","evidence":"Co-IP of TXNIP–GLUT1 with clathrin inhibitor experiments, AMPK-TXNIP phospho-mutants, ATM inhibitor/activator with S490A/D mutants and ex vivo muscle, quantitative proteomics of SNX27 interactome and surface proteome in retromer-depleted cells","pmids":["23453806","23776597","23563491"],"confidence":"High","gaps":["Relative quantitative contribution of each pathway to steady-state GLUT1 surface levels unknown","Whether TXNIP, ATM, and SNX27–retromer act in series or in parallel not resolved","Structural basis of TXNIP–GLUT1 interaction not determined"]},{"year":2014,"claim":"The 3.2 Å crystal structure of human GLUT1 in an inward-open conformation revealed the canonical MFS fold and enabled structural mapping of disease-causing mutations onto the transport pathway, providing the atomic framework for understanding alternating-access transport and pathogenic mechanism.","evidence":"X-ray crystallography at 3.2 Å, structural comparison with bacterial homologue XylE, mutation mapping","pmids":["24847886"],"confidence":"High","gaps":["Outward-open and occluded conformations not captured","Dynamics of the alternating-access cycle not resolved","No structure with bound glucose substrate"]},{"year":2019,"claim":"Myeloid-specific GLUT1 deletion demonstrated that GLUT1 is essential for macrophage glucose uptake, glycolysis, pentose phosphate pathway activity, and phagocytic capacity, directly linking GLUT1-dependent metabolism to innate immune function and atherosclerotic plaque stability.","evidence":"Conditional Slc2a1 knockout in myeloid cells, metabolic flux analysis, phagocytosis assays, Ldlr−/− atherosclerosis model","pmids":["30659108"],"confidence":"High","gaps":["Whether GLUT3 or other transporters can compensate over longer time frames not tested","Contribution of GLUT1-dependent glycolysis to other macrophage effector functions (cytokine secretion, antigen presentation) not fully explored"]},{"year":2022,"claim":"RAB21 was identified as the GTPase controlling fission of SNX27–retromer-decorated endosomal tubules for GLUT1 recycling; RAB21 depletion diverts GLUT1 to lysosomes, reduces glucose uptake, and triggers AMPK–ULK1 autophagy, closing the loop between endosomal sorting and metabolic signaling.","evidence":"RAB21 siRNA/shRNA, GLUT1 subcellular imaging, glucose uptake assays, AMPK-ULK1 pathway analysis, in vivo tumor growth","pmids":["35993307"],"confidence":"High","gaps":["Whether RAB21 directly contacts GLUT1 or acts only on the retromer tubule not determined","GEF and GAP for RAB21 in this context not identified","Integration with TXNIP- and ATM-dependent regulation not tested"]},{"year":null,"claim":"A complete structural view of the GLUT1 transport cycle (outward-open, occluded, substrate-bound states), the quantitative integration of TXNIP, ATM–GIPC1, and SNX27–retromer–RAB21 trafficking arms into a unified regulatory model, and the structural basis of the stomatin inhibitory interaction remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No outward-open or occluded-state human GLUT1 structure","Relative flux contributions of each trafficking pathway to surface GLUT1 not quantified in any single system","Structural basis of stomatin-mediated intrinsic activity inhibition unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,7,9,17,23,33,35]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[24]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,6,7,16,27,31,32]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[32,36]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[5,6]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,7,9,17,33,35]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[27,31,32,36]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[36]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[29,35]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,20,24,26]}],"complexes":[],"partners":["TXNIP","GIPC1","SNX27","RAB21","STOMATIN","BSG","CALNEXIN","CALRETICULIN"],"other_free_text":[]},"mechanistic_narrative":"SLC2A1 (GLUT1) is a ubiquitously expressed, 12-transmembrane-domain facilitated glucose uniporter of the major facilitator superfamily that mediates basal glucose uptake across the plasma membrane and also transports dehydroascorbic acid [PMID:3839598, PMID:24847886, PMID:9228080]. Its surface abundance is dynamically regulated by TXNIP-driven clathrin-mediated internalization (relieved by AMPK-dependent TXNIP degradation), SNX27–retromer–RAB21-mediated endosomal recycling back to the plasma membrane, and GIPC1 binding to a C-terminal PDZ motif that protects internalized GLUT1 from lysosomal degradation; ATM phosphorylation of Ser490 promotes GIPC1 association and surface retention, while stomatin binding to the C-terminal tail inhibits intrinsic transport activity without altering surface levels [PMID:23453806, PMID:23563491, PMID:35993307, PMID:19016655, PMID:23776597, PMID:11287341]. GLUT1 is the predominant glucose transporter at the blood–brain barrier and in erythrocytes, and heterozygous loss-of-function mutations cause GLUT1 deficiency syndrome, characterized by hypoglycorrhachia, seizures, and developmental delay [PMID:2211679, PMID:1714544, PMID:10980529]. GLUT1 also serves as the obligate receptor for HTLV-1 and HTLV-2 entry, and its differential expression programs distinct metabolic fates in effector versus regulatory T cells [PMID:14622599, PMID:21317389]."},"prefetch_data":{"uniprot":{"accession":"P11166","full_name":"Solute carrier family 2, facilitated glucose transporter member 1","aliases":["Glucose transporter type 1, erythrocyte/brain","GLUT-1","HepG2 glucose transporter"],"length_aa":492,"mass_kda":54.1,"function":"Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed:10227690, PubMed:10954735, PubMed:18245775, PubMed:19449892, PubMed:25982116, PubMed:27078104, PubMed:32860739). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed:18245775, PubMed:19449892). Most important energy carrier of the brain: present at the blood-brain barrier and assures the energy-independent, facilitative transport of glucose into the brain (PubMed:10227690). In association with BSG and NXNL1, promotes retinal cone survival by increasing glucose uptake into photoreceptors (By similarity). Required for mesendoderm differentiation (By similarity)","subcellular_location":"Cell membrane; Melanosome; Photoreceptor inner segment","url":"https://www.uniprot.org/uniprotkb/P11166/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC2A1","classification":"Not Classified","n_dependent_lines":527,"n_total_lines":1208,"dependency_fraction":0.43625827814569534},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000117394","cell_line_id":"CID001326","localizations":[{"compartment":"vesicles","grade":3}],"interactors":[{"gene":"HSP90AB1","stoichiometry":0.2},{"gene":"HSP90AB2P","stoichiometry":0.2},{"gene":"VAMP3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001326","total_profiled":1310},"omim":[{"mim_id":"617447","title":"PABP-DEPENDENT POLY(A) NUCLEASE 2; PAN2","url":"https://www.omim.org/entry/617447"},{"mim_id":"616158","title":"NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES; NEDRIHF","url":"https://www.omim.org/entry/616158"},{"mim_id":"615603","title":"CALCINEURIN-LIKE PHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; CPPED1","url":"https://www.omim.org/entry/615603"},{"mim_id":"615227","title":"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 3; C1QL3","url":"https://www.omim.org/entry/615227"},{"mim_id":"614847","title":"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12","url":"https://www.omim.org/entry/614847"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Centriolar satellite","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"placenta","ntpm":92.7}],"url":"https://www.proteinatlas.org/search/SLC2A1"},"hgnc":{"alias_symbol":["DYT18","DYT9","GLUT-1"],"prev_symbol":["GLUT1","GLUT","HTLVR","CSE"]},"alphafold":{"accession":"P11166","domains":[{"cath_id":"1.20.1250.20","chopping":"10-207","consensus_level":"medium","plddt":95.4507,"start":10,"end":207},{"cath_id":"1.20.1250.20","chopping":"257-470","consensus_level":"medium","plddt":90.6369,"start":257,"end":470}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11166","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11166-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11166-F1-predicted_aligned_error_v6.png","plddt_mean":90.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC2A1","jax_strain_url":"https://www.jax.org/strain/search?query=SLC2A1"},"sequence":{"accession":"P11166","fasta_url":"https://rest.uniprot.org/uniprotkb/P11166.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11166/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11166"}},"corpus_meta":[{"pmid":"23506862","id":"PMC_23506862","title":"The SLC2 (GLUT) family of membrane transporters.","date":"2013","source":"Molecular aspects of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23506862","citation_count":961,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15389572","id":"PMC_15389572","title":"Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.","date":"2005","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15389572","citation_count":958,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12568659","id":"PMC_12568659","title":"Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins.","date":"2003","source":"The British journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/12568659","citation_count":611,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2211679","id":"PMC_2211679","title":"Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2211679","citation_count":521,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8221565","id":"PMC_8221565","title":"Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.","date":"1993","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8221565","citation_count":485,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14622599","id":"PMC_14622599","title":"The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/14622599","citation_count":326,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1706526","id":"PMC_1706526","title":"The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1706526","citation_count":177,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31324056","id":"PMC_31324056","title":"Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31324056","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16497725","id":"PMC_16497725","title":"A mouse model for Glut-1 haploinsufficiency.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16497725","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9776278","id":"PMC_9776278","title":"FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.","date":"1998","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9776278","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8325893","id":"PMC_8325893","title":"Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8325893","citation_count":137,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11603379","id":"PMC_11603379","title":"Autosomal dominant glut-1 deficiency syndrome and familial epilepsy.","date":"2001","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11603379","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8051147","id":"PMC_8051147","title":"Topology of the Glut 1 glucose transporter deduced from glycosylation scanning mutagenesis.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8051147","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11738057","id":"PMC_11738057","title":"Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.","date":"2001","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/11738057","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12417042","id":"PMC_12417042","title":"Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.","date":"2002","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/12417042","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10980529","id":"PMC_10980529","title":"Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome.","date":"2000","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10980529","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30659108","id":"PMC_30659108","title":"Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30659108","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17192790","id":"PMC_17192790","title":"Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma.","date":"2006","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/17192790","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8349608","id":"PMC_8349608","title":"Rapid activation of GLUT-1 glucose transporter following inhibition of oxidative phosphorylation in clone 9 cells.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8349608","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10484371","id":"PMC_10484371","title":"GLUT-4myc ectopic expression in L6 myoblasts generates a GLUT-4-specific pool conferring insulin sensitivity.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10484371","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3028891","id":"PMC_3028891","title":"Polymorphic human glucose transporter gene (GLUT) is on chromosome 1p31.3----p35.","date":"1987","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/3028891","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11287341","id":"PMC_11287341","title":"Overexpression of stomatin depresses GLUT-1 glucose transporter activity.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11287341","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25132463","id":"PMC_25132463","title":"Increased glucose and placental GLUT-1 in large infants of obese nondiabetic mothers.","date":"2014","source":"American journal of obstetrics and gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/25132463","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30202104","id":"PMC_30202104","title":"Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3.","date":"2018","source":"Nature chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30202104","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21227456","id":"PMC_21227456","title":"Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.","date":"2010","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/21227456","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32352752","id":"PMC_32352752","title":"GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier.","date":"2020","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32352752","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31469221","id":"PMC_31469221","title":"Synthesis of Indomorphan Pseudo-Natural Product Inhibitors of Glucose Transporters GLUT-1 and -3.","date":"2019","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/31469221","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20220543","id":"PMC_20220543","title":"Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.","date":"2010","source":"Nuclear medicine communications","url":"https://pubmed.ncbi.nlm.nih.gov/20220543","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1581603","id":"PMC_1581603","title":"Pattern of glucose transporter (Glut 1) expression in embryonic brains is related to maturation of blood-brain barrier tightness.","date":"1992","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/1581603","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21832227","id":"PMC_21832227","title":"Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.","date":"2011","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21832227","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12771048","id":"PMC_12771048","title":"GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?","date":"2003","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/12771048","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17080242","id":"PMC_17080242","title":"Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.","date":"2006","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17080242","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22681646","id":"PMC_22681646","title":"GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.","date":"2012","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/22681646","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21791420","id":"PMC_21791420","title":"Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21791420","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21574259","id":"PMC_21574259","title":"Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.","date":"2010","source":"Diagnostic cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/21574259","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7656423","id":"PMC_7656423","title":"Ontogenic expression of the erythroid-type glucose transporter (Glut 1) in the telencephalon of the mouse: correlation to the tightening of the blood-brain barrier.","date":"1995","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7656423","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28623979","id":"PMC_28623979","title":"Placental glucose transporter (GLUT)-1 is down-regulated in preeclampsia.","date":"2017","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/28623979","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36048765","id":"PMC_36048765","title":"Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/36048765","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19016655","id":"PMC_19016655","title":"An essential role for the Glut1 PDZ-binding motif in growth factor regulation of Glut1 degradation and trafficking.","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19016655","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19289587","id":"PMC_19289587","title":"Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids.","date":"2009","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19289587","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12667615","id":"PMC_12667615","title":"The impact of N- and O-glycosylation on the functions of Glut-1 transporter in human thyroid anaplastic cells.","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12667615","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23108021","id":"PMC_23108021","title":"IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations.","date":"2013","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23108021","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8662691","id":"PMC_8662691","title":"The glut 1 glucose transporter interacts with calnexin and calreticulin.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8662691","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20395120","id":"PMC_20395120","title":"Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.","date":"2010","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/20395120","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8453764","id":"PMC_8453764","title":"Ontogeny of the erythroid/HepG2-type glucose transporter (GLUT-1) in the rat nervous system.","date":"1993","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8453764","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23227892","id":"PMC_23227892","title":"Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.","date":"2012","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23227892","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10364200","id":"PMC_10364200","title":"Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10364200","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28785055","id":"PMC_28785055","title":"Suppression of diabetic retinopathy with GLUT1 siRNA.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28785055","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29374351","id":"PMC_29374351","title":"miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.","date":"2018","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/29374351","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7678253","id":"PMC_7678253","title":"Effect of glucose deprivation of GLUT 1 expression in 3T3-L1 adipocytes.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7678253","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11231353","id":"PMC_11231353","title":"Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy.","date":"2001","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/11231353","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30609116","id":"PMC_30609116","title":"Liposomes actively recognizing the glucose transporter GLUT1 and integrin αv β3 for dual-targeting of glioma.","date":"2019","source":"Archiv der Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/30609116","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32556218","id":"PMC_32556218","title":"Steroids Regulate SLC2A1 and SLC2A3 to Deliver Glucose Into Trophectoderm for Metabolism via Glycolysis.","date":"2020","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32556218","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28440026","id":"PMC_28440026","title":"miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1.","date":"2017","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28440026","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23776597","id":"PMC_23776597","title":"ATM and GLUT1-S490 phosphorylation regulate GLUT1 mediated transport in skeletal muscle.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23776597","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35993307","id":"PMC_35993307","title":"RAB21 controls autophagy and cellular energy homeostasis by regulating retromer-mediated recycling of SLC2A1/GLUT1.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/35993307","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34070830","id":"PMC_34070830","title":"GLUT-1 Enhances Glycolysis, Oxidative Stress, and Fibroblast Proliferation in Keloid.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34070830","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25417118","id":"PMC_25417118","title":"Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases.","date":"2014","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25417118","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"13129590","id":"PMC_13129590","title":"Glucose transporter type1 (GLUT-1) deficiency.","date":"2003","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/13129590","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29303961","id":"PMC_29303961","title":"Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29303961","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11546675","id":"PMC_11546675","title":"Stimulation of GLUT-1 glucose transporter expression in response to hyperosmolarity.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11546675","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11836704","id":"PMC_11836704","title":"Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.","date":"2002","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11836704","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10229326","id":"PMC_10229326","title":"N-glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells.","date":"1999","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/10229326","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37858199","id":"PMC_37858199","title":"Downregulation of the glucose transporter GLUT 1 in the cerebral microvasculature contributes to postoperative neurocognitive disorders in aged mice.","date":"2023","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/37858199","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2017192","id":"PMC_2017192","title":"Glucose deprivation induces the selective accumulation of hexose transporter protein GLUT-1 in the plasma membrane of normal rat kidney cells.","date":"1991","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/2017192","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16391802","id":"PMC_16391802","title":"Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.","date":"2006","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16391802","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29797802","id":"PMC_29797802","title":"Glucose transporter-1 (GLUT-1) expression in psoriasis: correlation with disease severity.","date":"2018","source":"International journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/29797802","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14499345","id":"PMC_14499345","title":"Sphingomyelin/cholesterol ratio: an important determinant of glucose transport mediated by GLUT-1 in 3T3-L1 preadipocytes.","date":"2003","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/14499345","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16515729","id":"PMC_16515729","title":"Role for GLUT1 in diabetic glomerulosclerosis.","date":"2006","source":"Expert reviews in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16515729","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23340081","id":"PMC_23340081","title":"The many faces of Glut1 deficiency syndrome.","date":"2013","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23340081","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15509684","id":"PMC_15509684","title":"Extracutaneous infantile haemangioma is also Glut1 positive.","date":"2004","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15509684","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30895386","id":"PMC_30895386","title":"Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes.","date":"2019","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30895386","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30480843","id":"PMC_30480843","title":"Membrane-enriched solute carrier family 2 member 1 (SLC2A1/GLUT1) in psoriatic keratinocytes confers sensitivity to 2-deoxy-D-glucose (2-DG) treatment.","date":"2018","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30480843","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2100513","id":"PMC_2100513","title":"Vanadate regulates glucose transporter (Glut-1) expression in NIH3T3 mouse fibroblasts.","date":"1990","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2100513","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33916948","id":"PMC_33916948","title":"Oxidative Stress-Induced Sirtuin1 Downregulation Correlates to HIF-1α, GLUT-1, and VEGF-A Upregulation in Th1 Autoimmune Hashimoto's Thyroiditis.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33916948","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35596882","id":"PMC_35596882","title":"Therapeutic implications of glucose transporters (GLUT) in cerebral ischemia.","date":"2022","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/35596882","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1915077","id":"PMC_1915077","title":"Expression of the low Km GLUT-1 glucose transporter is turned on in perivenous hepatocytes of insulin-deficient diabetic rats.","date":"1991","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1915077","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33580997","id":"PMC_33580997","title":"TFAP2A-induced SLC2A1-AS1 promotes cancer cell proliferation.","date":"2021","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33580997","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36068393","id":"PMC_36068393","title":"Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma.","date":"2022","source":"Journal of natural medicines","url":"https://pubmed.ncbi.nlm.nih.gov/36068393","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7690040","id":"PMC_7690040","title":"Novel control of the position-dependent expression of genes in hepatocytes. The GLUT-1 transporter.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7690040","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34580846","id":"PMC_34580846","title":"GLUT-1 Expression in Breast Cancer.","date":"2022","source":"Turk patoloji dergisi","url":"https://pubmed.ncbi.nlm.nih.gov/34580846","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36739076","id":"PMC_36739076","title":"Characterization of the effect of the GLUT-1 inhibitor BAY-876 on T cells and macrophages.","date":"2023","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36739076","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31423271","id":"PMC_31423271","title":"Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31423271","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11189940","id":"PMC_11189940","title":"Correlation of Glut-1 glucose transporter expression with.","date":"2000","source":"European journal of nuclear medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11189940","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24824604","id":"PMC_24824604","title":"A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood.","date":"2014","source":"Cephalalgia : an international journal of headache","url":"https://pubmed.ncbi.nlm.nih.gov/24824604","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12009942","id":"PMC_12009942","title":"Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 Cells.","date":"2002","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12009942","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8928771","id":"PMC_8928771","title":"Glycogen: a carbohydrate source for GLUT-1 glycosylation during glucose deprivation of 3T3-L1 adipocytes.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8928771","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26092229","id":"PMC_26092229","title":"GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.","date":"2015","source":"International journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26092229","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16785788","id":"PMC_16785788","title":"GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.","date":"2006","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/16785788","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12932118","id":"PMC_12932118","title":"Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.","date":"2003","source":"Annals of nuclear medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12932118","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29128957","id":"PMC_29128957","title":"Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases.","date":"2017","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/29128957","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26101475","id":"PMC_26101475","title":"Clinical significance of COX-2, GLUT-1 and VEGF expressions in endometrial cancer tissues.","date":"2015","source":"Pakistan journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26101475","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16450901","id":"PMC_16450901","title":"Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.","date":"2005","source":"Acta cytologica","url":"https://pubmed.ncbi.nlm.nih.gov/16450901","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7491913","id":"PMC_7491913","title":"Stimulation of GLUT-1 glucose transporter expression in response to exposure to calcium ionophore A-23187.","date":"1995","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7491913","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27795705","id":"PMC_27795705","title":"CD63 and GLUT-1 Overexpression Could Predict a Poor Clinical Outcome in GIST: A Study of 54 Cases with Follow-Up.","date":"2016","source":"Gastroenterology research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/27795705","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8772449","id":"PMC_8772449","title":"Induction of GLUT-1 mRNA in response to inhibition of oxidative phosphorylation: role of increased [Ca2+]i.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8772449","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8972727","id":"PMC_8972727","title":"Stimulation of glucose transport in Clone 9 cells by insulin and thyroid hormone: role of GLUT-1 activation.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8972727","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1520263","id":"PMC_1520263","title":"Glucose regulates its transport in L8 myocytes by modulating cellular trafficking of the transporter GLUT-1.","date":"1992","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/1520263","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35357376","id":"PMC_35357376","title":"Antihyperglycemic effect of an anthocyanin, cyanidin-3-O-glucoside, is achieved by regulating GLUT-1 via the Wnt/β-catenin-WISP1 signaling pathway.","date":"2022","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/35357376","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9154929","id":"PMC_9154929","title":"Structural domains that contribute to substrate specificity in facilitated glucose transporters are distinct from those involved in kinetic function: studies with GLUT-1/GLUT-2 chimeras.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9154929","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21317389","id":"PMC_21317389","title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21317389","citation_count":1722,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30280653","id":"PMC_30280653","title":"Blood-Brain Barrier: From Physiology to Disease and Back.","date":"2019","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30280653","citation_count":1645,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3839598","id":"PMC_3839598","title":"Sequence and structure of a human glucose transporter.","date":"1985","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/3839598","citation_count":1396,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26590417","id":"PMC_26590417","title":"Establishment and Dysfunction of the Blood-Brain Barrier.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26590417","citation_count":1304,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24847886","id":"PMC_24847886","title":"Crystal structure of the human glucose transporter GLUT1.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/24847886","citation_count":599,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1714544","id":"PMC_1714544","title":"Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay.","date":"1991","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1714544","citation_count":550,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23453806","id":"PMC_23453806","title":"AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23453806","citation_count":543,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25910212","id":"PMC_25910212","title":"Widespread macromolecular interaction perturbations in human genetic disorders.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910212","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23563491","id":"PMC_23563491","title":"A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport.","date":"2013","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23563491","citation_count":443,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2656669","id":"PMC_2656669","title":"Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2656669","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15166316","id":"PMC_15166316","title":"Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms.","date":"2004","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15166316","citation_count":417,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3170580","id":"PMC_3170580","title":"Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3170580","citation_count":413,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9228080","id":"PMC_9228080","title":"Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9228080","citation_count":380,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29656893","id":"PMC_29656893","title":"DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/29656893","citation_count":379,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8839927","id":"PMC_8839927","title":"Structure, function, and regulation of the mammalian facilitative glucose transporter gene family.","date":"1996","source":"Annual review of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/8839927","citation_count":348,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25957687","id":"PMC_25957687","title":"Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25957687","citation_count":334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2211693","id":"PMC_2211693","title":"Cell surface labeling of glucose transporter isoform GLUT4 by bis-mannose photolabel. Correlation with stimulation of glucose transport in rat adipose cells by insulin and phorbol ester.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2211693","citation_count":319,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22810586","id":"PMC_22810586","title":"Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22810586","citation_count":319,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21707071","id":"PMC_21707071","title":"Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.","date":"2011","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/21707071","citation_count":308,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52166,"output_tokens":7003,"usd":0.130772},"stage2":{"model":"claude-opus-4-6","input_tokens":10619,"output_tokens":3785,"usd":0.22158},"total_usd":0.763268,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":63669,"output_tokens":8827,"usd":0.161706},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12928,"output_tokens":4060,"usd":0.24921}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Glycosylation scanning mutagenesis of Glut1 confirmed the 12 transmembrane helix topology in vivo (Xenopus oocytes); insertion of an exofacial epitope tag into the NH2 terminus, large central loop, or second, third, or fifth exofacial loop had no dramatic effect on transport activity, whereas insertion into other soluble domains abolished or significantly reduced transport activity, mapping functionally critical intracellular/extracellular loops.\",\n      \"method\": \"Scanning mutagenesis with glycosylation reporter insertions; in vitro rabbit reticulocyte lysate; in vivo Xenopus oocyte expression; 2-deoxyglucose uptake assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in oocytes + mutagenesis + functional transport readout; single rigorous paper with multiple orthogonal methods\",\n      \"pmids\": [\"8051147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GLUT-1 functions as the receptor for both HTLV-1 and HTLV-2; the receptor-binding domains of HTLV envelope glycoproteins interact with GLUT-1 and inhibit glucose transport; ectopic GLUT-1 (but not GLUT-3) restores HTLV infection abrogated by GLUT-1 siRNA or interfering envelope glycoproteins.\",\n      \"method\": \"siRNA knockdown of GLUT-1; ectopic expression of GLUT-1 vs GLUT-3; cytochalasin B inhibition of glucose transport; infection assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (siRNA, ectopic expression, pharmacological inhibition) with rigorous specificity controls in a high-impact journal\",\n      \"pmids\": [\"14622599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Glut1 interacts with the ER chaperones calnexin and calreticulin in a glycosylation-dependent manner; a non-glycosylated Glut1 mutant (AGGT155) failed to associate with either chaperone, establishing that N-linked oligosaccharide on Glut1 is required for these interactions during folding in the endoplasmic reticulum.\",\n      \"method\": \"Cell-free translation in rabbit reticulocyte lysate with canine pancreatic microsomes; co-immunoprecipitation with anti-calnexin antiserum; UV crosslinking; glycosylation-deficient mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in cell-free system, mutagenesis of glycosylation site, crosslinking validation\",\n      \"pmids\": [\"8662691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Overexpression of stomatin (band 7.2b) reduces basal GLUT-1 glucose transport activity by 35–70% without decreasing plasma membrane GLUT-1 content; stomatin co-immunoprecipitates with GLUT-1 and binds directly to a GST fusion protein containing the COOH-terminal 42-amino acid segment of GLUT-1 but not to the central loop, indicating protein–protein interaction that reduces the intrinsic activity of plasma-membrane-resident GLUT-1.\",\n      \"method\": \"Stable transfection; glucose transport assay; co-immunoprecipitation; GST pulldown with GLUT-1 C-terminal domain fragments\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (transport assay, co-IP, domain-specific GST pulldown) in a single rigorous study\",\n      \"pmids\": [\"11287341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"R126H missense mutation in GLUT1 causes autosomal dominant Glut-1 deficiency syndrome; in vitro mutagenesis in Xenopus oocytes showed that R126H results in reduced Vmax for 3-O-methyl-D-glucose and dehydroascorbic acid transport, with normal protein expression at the membrane, demonstrating the mutation impairs transport activity rather than protein targeting.\",\n      \"method\": \"In vitro mutagenesis; Xenopus oocyte expression; radiolabeled sugar transport kinetics (Vmax determination); Western blot of oocyte membranes\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in Xenopus oocytes with kinetic analysis and mutagenesis, directly establishing pathogenicity mechanism\",\n      \"pmids\": [\"11603379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The C-terminal PDZ-binding motif of Glut1 is required for maximal cytokine-stimulated cell surface localization and protection from lysosomal degradation upon growth factor withdrawal; the PDZ-domain protein GIPC binds to Glut1 partly via this motif and promotes Glut1 trafficking to the cell surface; GIPC deficiency reduces surface Glut1 and glucose uptake.\",\n      \"method\": \"Deletion and point mutagenesis of PDZ-binding motif; flow cytometry and immunofluorescence for surface Glut1; lysosomal inhibitor experiments; co-immunoprecipitation of GIPC; siRNA knockdown of GIPC\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (mutagenesis, co-IP, siRNA, localization imaging, transport assay) with strong mechanistic resolution\",\n      \"pmids\": [\"19016655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ATM kinase phosphorylates GLUT1 at serine 490 (S490); ATM inhibition reduces cell-surface GLUT1, glucose and dehydroascorbic acid (DHA) transport, and GLUT1 association with GIPC1; S490A mutation decreases transport and surface GLUT1, while S490D increases them, demonstrating that ATM-mediated S490 phosphorylation promotes GLUT1 cell-surface localization and transport activity through upregulation of the GLUT1–GIPC1 interaction.\",\n      \"method\": \"ATM inhibitor and activator (doxorubicin) treatment; S490A and S490D point mutagenesis; cell-surface GLUT1 quantification; radiolabeled glucose/DHA transport assay; co-immunoprecipitation of GLUT1/GIPC1; skeletal muscle ex vivo transport assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — phospho-mimetic/phospho-dead mutagenesis combined with pharmacological perturbation, co-IP, and functional transport readout in both cell lines and tissue\",\n      \"pmids\": [\"23776597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Mutations in SLC2A1 cause stomatin-deficient cryohydrocytosis (sdCHC), producing both loss of glucose transport and a cation leak; Xenopus oocyte expression studies demonstrated these two gain-of-function and loss-of-function consequences of specific SLC2A1 mutations; 3D modeling of Glut1 was used to propose structural mechanisms; stomatin loss during reticulocyte maturation occurs via endocytosis.\",\n      \"method\": \"Sanger sequencing; Xenopus oocyte expression with functional transport and cation flux assays; 3D structural modeling; flow cytometry of erythropoiesis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — functional reconstitution in Xenopus oocytes with two distinct readouts (glucose transport and cation leak) directly linking mutations to mechanism\",\n      \"pmids\": [\"21791420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Rapid stimulation of glucose transport (7.5-fold at 2 h) following inhibition of oxidative phosphorylation in Clone 9 cells is mediated by activation of GLUT-1 transporters already present in the plasma membrane, not by translocation of additional transporters; plasma membrane GLUT-1 abundance increases only slightly, ruling out recruitment as the dominant early mechanism.\",\n      \"method\": \"Immunofluorescence microscopy; subcellular fractionation + Western blot; cell-surface biotinylation + Western blot; [3H]cytochalasin B binding to plasma membrane fractions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — four independent, orthogonal methods all converging on the same mechanistic conclusion\",\n      \"pmids\": [\"8349608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The structural determinants of substrate specificity in GLUT-1/GLUT-2 chimeras are distinct from those governing glucose transport kinetics: the N-terminal 87 amino acids of GLUT-1 (when substituted into GLUT-2) reduce alternative substrate transport without altering Km for 2-deoxyglucose, while the GLUT-2 C-terminal tail shifts Km but does not confer alternative substrate transport; N-linked glycosylation at Asn62 of GLUT-2 affects Km independently of substrate specificity.\",\n      \"method\": \"Recombinant adenoviral expression of chimeric and mutant transporters in CV-1 cells; 2-deoxyglucose and alternative substrate (fructose, arabinose, streptozotocin) uptake assays; glycosylation mutant (N62Q)\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic chimera and mutagenesis approach with functional transport readouts establishing structure–function relationships\",\n      \"pmids\": [\"9154929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The transcription factor Sp1 binds to the -102/-82 region of the GLUT-1 promoter and is essential for high GLUT-1 transcriptional activity in neonatal cardiomyocytes; Sp1 binding is detected during the fetal state but not adulthood, and Sp1 is markedly downregulated in heart and skeletal muscle postnatally, accounting for perinatal repression of GLUT-1 in cardiac muscle.\",\n      \"method\": \"Transient transfection with GLUT-1 promoter-reporter constructs; electrophoretic mobility shift assay (EMSA); Sp1 site mutagenesis; nuclear run-on/Western blot in cardiac tissue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — promoter mutagenesis, EMSA, and in vivo transcriptional assay with developmental tissue samples\",\n      \"pmids\": [\"10364200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"N-glycosylation of GLUT-1 is required for proper plasma membrane trafficking and full transport activity in thyroid anaplastic carcinoma cells: tunicamycin (N-glycosylation inhibitor) caused 50% decrease in glucose transport; O-glycosylation inhibitor benzyl-N-acetylgalactosamine dramatically inhibited glucose transport, and Glut-1 was shown to bind the O-glycan-specific lectin jacalin, indicating O-linked glycans are also essential for transport function.\",\n      \"method\": \"Tunicamycin and benzyl-N-acetylgalactosamine treatment; deoxymannojirimycin and swainsonine (oligosaccharide processing inhibitors); jacalin lectin binding; radiolabeled glucose transport assay; cell fractionation\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological inhibitors with distinct specificities and functional readout, single lab\",\n      \"pmids\": [\"12667615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"N-glycosylation of GLUT-1 in leukemic cells increases transporter affinity for glucose (lower Km) without changing Vmax; tunicamycin inhibits N-glycosylation, produces a 2–2.5-fold decrease in glucose Km, and causes appearance of lower-molecular-weight (30–40 kDa) GLUT-1 species, demonstrating that N-linked glycosylation modulates the kinetic properties of GLUT-1.\",\n      \"method\": \"Tunicamycin treatment; 2-deoxyglucose uptake kinetics (Km, Vmax); Western blot of GLUT-1; [3H]mannose incorporation\",\n      \"journal\": \"Leukemia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — kinetic analysis with pharmacological tool, single lab, consistent with other glycosylation studies\",\n      \"pmids\": [\"10229326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Transfection of GLUT-1 into AtT-20ins cells increases glucose transport capacity (low Km ~4 mM, increased Vmax) but does not confer glucose-stimulated insulin secretion, in contrast to GLUT-2 transfection; despite dramatic differences in transport affinity and capacity, overall rates of glucose metabolism are similar between GLUT-1 and GLUT-2 transfectants, indicating GLUT-2's effect on insulin secretion is not related to altered glucose metabolism rate.\",\n      \"method\": \"Stable transfection; 3-O-methyl glucose uptake kinetics; [5-3H]glucose usage measurement; static incubation and perifusion insulin secretion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution by transfection with kinetic transport analysis and functional insulin secretion readout; orthogonal metabolic measurements\",\n      \"pmids\": [\"8325893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"GLUT-1 glucose transporter is selectively localized to the blood-brain barrier (capillary endothelium) in bovine brain; essentially 100% of cytochalasin B binding sites in BBB membranes correspond to GLUT-1, confirmed by quantitative Western blot using purified erythrocyte GLUT-1 as standard; in situ hybridization shows GLUT-1 mRNA restricted to microvascular endothelium with minimal neuronal/glial expression.\",\n      \"method\": \"Quantitative Western blotting with purified standard; [3H]cytochalasin B binding; in situ hybridization with antisense/sense riboprobes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal quantitative methods; foundational localization paper with functional implication for BBB glucose transport\",\n      \"pmids\": [\"2211679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Glucose deprivation induces selective accumulation of glycosylated GLUT-1 (55 kDa) in the plasma membrane of NRK cells, increasing hexose transport; tunicamycin-treated cells accumulate the non-glycosylated GLUT-1 form (38 kDa) intracellularly rather than at the plasma membrane, demonstrating that N-linked glycosylation is required for efficient plasma membrane targeting of GLUT-1.\",\n      \"method\": \"Subcellular fractionation; [3H]cytochalasin B binding; immunofluorescence microscopy; tunicamycin treatment; Western blot\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (fractionation, binding, imaging) in single lab; consistent with other glycosylation/trafficking findings\",\n      \"pmids\": [\"2017192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Glucose regulates GLUT-1 trafficking in L8 myocytes: high glucose reduces plasma membrane GLUT-1 (measured by cytochalasin B binding and Western blot) and decreases transport, while low glucose increases plasma membrane GLUT-1 and transport; changes in intrinsic transporter activity were not observed, indicating autoregulation operates through parallel changes in the number of GLUT-1 transporters at the plasma membrane.\",\n      \"method\": \"Subcellular fractionation; [3H]cytochalasin B binding; Western blot; 2-deoxy-D-[3H]glucose uptake assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (binding, Western, transport) with bidirectional experimental manipulation\",\n      \"pmids\": [\"1520263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RAB21 GTPase regulates retromer-mediated recycling of SLC2A1/GLUT1: RAB21 depletion mis-sorts GLUT1 to lysosomes rather than recycling it to the plasma membrane, reduces glucose uptake, and activates the AMPK–ULK1 pathway to increase autophagic flux; RAB21 depletion accumulates the SNX27-containing retromer complex on enlarged perinuclear endosomes.\",\n      \"method\": \"RAB21 siRNA/KO; GLUT1 localization by immunofluorescence and subcellular fractionation; glucose uptake assay; autophagy flux measurement; immunoprecipitation of retromer components; in vivo xenograft tumor model\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (localization, transport, autophagic flux, retromer co-localization) with both in vitro and in vivo validation\",\n      \"pmids\": [\"35993307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Myeloid-specific deletion of Slc2a1 (GLUT1) in bone marrow-derived macrophages abolishes glucose uptake, reduces glycolysis and pentose phosphate pathway activity, and results in a mixed inflammatory phenotype with reduced pro- and anti-inflammatory markers; GLUT1-deficient macrophages show defective phagocytic capacity and, in Ldlr mice, contribute to unstable atherosclerotic lesion formation.\",\n      \"method\": \"Conditional Slc2a1 knockout (myeloid-specific Cre); glucose uptake assay; extracellular flux analysis (Seahorse); metabolomics; flow cytometry; phagocytosis assay; atherosclerosis model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple metabolic and functional readouts, in vivo disease model validation\",\n      \"pmids\": [\"30659108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hyperosmolarity stimulates GLUT-1 expression via two mechanisms: enhanced transcription (shown by promoter-reporter assay requiring the proximal -44 bp region) and stabilization of GLUT-1 mRNA (half-life increases from 2 h to 8 h), leading to increased GLUT-1 protein and glucose transport; early phase transport stimulation is independent of changes in GLUT-1 content.\",\n      \"method\": \"GLUT-1 mRNA half-life measurement with actinomycin D; promoter-reporter transfection; Western blot; glucose transport assay; sorbitol measurement\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter mapping combined with mRNA stability assay and transport readout, single lab\",\n      \"pmids\": [\"11546675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Calcium ionophore A-23187 stimulates GLUT-1 gene expression in Clone 9 cells through both enhanced transcription (1.5–1.7-fold in nuclear run-on assay) and mRNA stabilization (half-life increases from 1.5 h to 5.5 h), resulting in increased GLUT-1 protein and 10-fold elevated glucose transport; chelation of intracellular Ca2+ with BAPTA/EGTA prevents the response.\",\n      \"method\": \"Nuclear run-on transcription assay; mRNA half-life measurement with actinomycin D; Western blot; cytochalasin B-inhibitable 3-O-methyl-D-glucose transport assay; intracellular Ca2+ chelation\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — nuclear run-on + mRNA stability + transport readout in a single study, single lab\",\n      \"pmids\": [\"7491913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Increased cytosolic Ca2+ (raised by ionomycin/A-23187/thapsigargin) enhances GLUT-1 mRNA expression, but the rise in [Ca2+]i caused by azide (inhibition of oxidative phosphorylation) is insufficient in magnitude to mediate azide-induced GLUT-1 mRNA induction: BAPTA preloading prevents ionomycin- but not azide-stimulated GLUT-1 mRNA induction, dissociating the two pathways.\",\n      \"method\": \"Calcium chelation with BAPTA; [Ca2+]i measurement; GLUT-1 mRNA quantification with Northern blot; ionomycin/azide/thapsigargin treatment; comparison of kinetics\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with multiple agents and Ca2+ measurement, single lab\",\n      \"pmids\": [\"8772449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CDK6 promotes SLC2A1/GLUT1 transcription by maintaining H3K27ac, H4K8ac, and H3K4me1 levels at the SLC2A1 enhancer; isoginkgetin binds the N-terminus of CDK6 and promotes its degradation, reducing enhancer activity, suppressing GLUT1 expression, decreasing glucose uptake, and activating the AMPK–ULK1 autophagy pathway.\",\n      \"method\": \"CDK6 molecular docking; thermal shift assay; ChIP for histone marks (H3K27ac, H4K8ac, H3K4me1) at SLC2A1 enhancer; CDK6 overexpression/knockdown; GLUT1 reporter; glucose uptake assay; autophagy markers; xenograft and primary HCC mouse model\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct CDK6-isoginkgetin binding confirmed biochemically, ChIP for enhancer marks, functional rescue experiments with multiple orthogonal readouts in vitro and in vivo\",\n      \"pmids\": [\"36048765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"miR-328 directly targets the 3'-UTR of SLC2A1/GLUT1 to suppress its expression, as demonstrated by luciferase reporter assay; miR-328 overexpression reduces GLUT1 protein and limits glycolysis (glucose consumption and lactate production) in colon cancer cells.\",\n      \"method\": \"Luciferase 3'-UTR reporter assay; Western blot; miR-328 overexpression; glycolysis metabolite measurement\",\n      \"journal\": \"Clinical & translational oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'-UTR reporter with Western blot validation, single lab\",\n      \"pmids\": [\"29374351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Thyroid hormone (T3) and insulin each stimulate GLUT-1-mediated glucose transport in Clone 9 cells; cell-surface biotinylation shows that the stimulatory effects of both hormones, especially in combination, exceed increases in plasma membrane GLUT-1 abundance, indicating that activation of pre-existing plasma-membrane GLUT-1 (increased intrinsic activity) is the primary mechanism.\",\n      \"method\": \"Cell-surface biotinylation; Western blot of plasma membrane fractions; glucose transport assay; hormone co-treatment\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — surface biotinylation combined with transport assay, single lab\",\n      \"pmids\": [\"8972727\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC2A1/GLUT1 is a 12-transmembrane-domain facilitative glucose transporter whose intrinsic activity is regulated by post-translational glycosylation (N- and O-linked), protein–protein interactions (stomatin inhibits activity via the COOH-terminal 42-aa domain; GIPC promotes surface trafficking via the C-terminal PDZ-binding motif; calnexin/calreticulin assist folding in a glycosylation-dependent manner), and phosphorylation (ATM kinase phosphorylates S490 to promote surface localization and GIPC1 association); its cell-surface abundance is dynamically regulated by glucose-dependent and growth-factor-dependent vesicular trafficking (involving RAB21-retromer recycling and lysosomal degradation pathways), transcriptional control by Sp1 and CDK6-dependent enhancer activity, and mRNA stabilization by calcium signaling and hyperosmotic stress; haploinsufficiency of SLC2A1 reduces glucose delivery across the blood-brain barrier, causing the spectrum of GLUT1 deficiency syndrome phenotypes, and GLUT-1 also serves as the cellular entry receptor for HTLV-1 and HTLV-2.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1985,\n      \"finding\": \"The primary structure of human GLUT1 (SLC2A1) was deduced from cDNA sequencing, revealing a ~500 amino acid protein with 12 predicted membrane-spanning domains, with the amino terminus, carboxyl terminus, and a central hydrophilic domain all predicted to lie on the cytoplasmic face.\",\n      \"method\": \"cDNA cloning and sequencing, structural analysis by fast atom bombardment mapping and gas phase Edman degradation of purified erythrocyte transporter\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original sequence determination with biochemical validation, foundational paper replicated extensively\",\n      \"pmids\": [\"3839598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"The human GLUT1 gene (designated GLUT) was mapped to chromosome 1p31.3–p35 (most likely 1p33), and a two-allele XbaI restriction-fragment-length polymorphism was identified.\",\n      \"method\": \"Somatic cell hybrid panel hybridization and in situ hybridization to metaphase chromosomes\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal mapping with two orthogonal methods\",\n      \"pmids\": [\"3028891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"GLUT1 is selectively and highly expressed at the blood-brain barrier (cerebral capillary endothelium); essentially 100% of glucose transporter binding sites at the BBB can be accounted for by the GLUT1 isoform.\",\n      \"method\": \"Quantitative Western blotting with purified erythrocyte GLUT1 standard, [3H]cytochalasin B binding assay, and in situ hybridization on bovine brain cortex\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal quantitative methods in a single study, widely replicated\",\n      \"pmids\": [\"2211679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"GLUT1 deficiency syndrome was established as a disease caused by defective glucose transport across the blood-brain barrier, resulting in persistent hypoglycorrhachia, seizures, and developmental delay.\",\n      \"method\": \"Clinical characterization combined with erythrocyte glucose transport assays and CSF glucose measurements\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional transport assays linked to clinical phenotype, landmark disease-defining paper\",\n      \"pmids\": [\"1714544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"GLUT1 expression is regulated as a stress-response gene: glucose starvation, calcium ionophore A23187, 2-mercaptoethanol, and tunicamycin all increase GLUT1 mRNA (50–300%) similarly to GRP-78, classifying GLUT1 as a member of the glucose-regulated protein (GRP) family of stress proteins.\",\n      \"method\": \"Northern blot analysis of GLUT1 and GRP-78 mRNA in L8 myocytes and NIH 3T3 fibroblasts under multiple stress conditions; glucose uptake assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal stress stimuli, two cell lines, replicated across conditions\",\n      \"pmids\": [\"1706526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Glucose deprivation induces selective accumulation of glycosylated GLUT1 (55 kDa) in the plasma membrane of NRK cells, increasing hexose transport; under glucose-fed conditions GLUT1 resides predominantly in intracellular membrane fractions.\",\n      \"method\": \"Subcellular fractionation, [3H]cytochalasin B binding, immunofluorescence microscopy, Western blotting\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization methods in a single study\",\n      \"pmids\": [\"2017192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Glucose autoregulates its own transport in L8 myocytes by modulating GLUT1 trafficking: decreased glucose concentration increases plasma membrane GLUT1 and transport activity with parallel reductions in intracellular GLUT1, without apparent changes in intrinsic transporter activity.\",\n      \"method\": \"[3H]cytochalasin B binding, Western blotting of subcellular fractions, 2-deoxy-D-[3H]glucose uptake assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — quantitative subcellular fractionation combined with functional transport assays\",\n      \"pmids\": [\"1520263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Inhibition of oxidative phosphorylation (azide treatment) causes rapid ~7.5-fold stimulation of GLUT1-mediated glucose transport in Clone 9 cells primarily through activation of pre-existing plasma membrane GLUT1, not translocation from intracellular pools.\",\n      \"method\": \"Immunofluorescence microscopy, differential centrifugation + Western blot, cell surface biotinylation, [3H]cytochalasin B binding\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — four independent orthogonal approaches reaching consistent conclusion\",\n      \"pmids\": [\"8349608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"GLUT1 topology was experimentally determined: the protein contains 12 membrane-spanning domains with cytoplasmic N- and C-termini and a large central cytoplasmic loop, consistent with the predicted model; insertion of an exofacial epitope into various loops confirmed this topology in vivo.\",\n      \"method\": \"Glycosylation scanning mutagenesis expressed in Xenopus oocytes (in vivo) and rabbit reticulocyte lysate (in vitro); 2-deoxyglucose uptake assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with functional readout in two expression systems\",\n      \"pmids\": [\"8051147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Transfection of GLUT1 (but not GLUT2) into AtT-20ins cells increases glucose transport affinity (Km ~4 mM vs 2 mM for untransfected cells) but does not confer glucose-stimulated insulin release, demonstrating that GLUT1 kinetics are insufficient to act as a glucose sensor in beta-cells.\",\n      \"method\": \"Stable transfection, 3-O-methyl glucose uptake kinetics, static incubation and perifusion insulin secretion assays, [5-3H]glucose usage\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — detailed kinetic analysis with functional insulin secretion readout\",\n      \"pmids\": [\"8325893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"During glucose deprivation of 3T3-L1 adipocytes, a lower molecular weight (37 kDa) underglycosylated isoform of GLUT1 appears; the 10-fold increase in transport activity requires new protein synthesis but involves only a small transient increase in GLUT1 mRNA, suggesting post-translational regulation and trafficking changes dominate.\",\n      \"method\": \"Glucose transport assays, Northern blot, Western blot with glycoforms, mannose/analog competition experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical approaches but mechanism of transport increase not fully resolved\",\n      \"pmids\": [\"7678253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"GLUT1 topology confirmed in vivo as 12 transmembrane helices; insertion into the NH2 terminus, large central loop, or exofacial loops 2, 3, and 5 had little effect on transport activity, whereas insertion into other soluble domains abolished or significantly reduced transport.\",\n      \"method\": \"Glycosylation scanning mutagenesis in Xenopus oocytes with 2-deoxyglucose uptake functional readout\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with functional validation\",\n      \"pmids\": [\"8051147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Exposure to calcium ionophore A-23187 stimulates GLUT1 gene expression via both enhanced transcription (1.5–1.7-fold by nuclear run-on) and mRNA stabilization (half-life increased from 1.5 h to 5.5 h), resulting in increased GLUT1 protein and glucose transport.\",\n      \"method\": \"Nuclear run-on transcription assays, actinomycin D mRNA decay experiments, Northern blot, Western blot, 3-O-methyl-D-glucose transport assays\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — nuclear run-on plus mRNA stability assays, multiple orthogonal methods\",\n      \"pmids\": [\"7491913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"GLUT1 interacts with the ER chaperones calnexin and calreticulin in a glycosylation-dependent manner; non-glycosylated GLUT1 mutants fail to associate with either chaperone, indicating that the N-linked oligosaccharide is essential for this interaction during GLUT1 folding in the ER.\",\n      \"method\": \"Cross-linking studies, co-immunoprecipitation with anti-calnexin antibody, in vitro translation in the presence of microsomal membranes using a truncated GLUT1 construct\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — co-IP with mutagenesis control (aglycosyl mutant) and UV crosslinking\",\n      \"pmids\": [\"8662691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Increased cytosolic calcium does not mediate the induction of GLUT1 mRNA in response to inhibition of oxidative phosphorylation by azide; although ionomycin raises [Ca2+]i and induces GLUT1 mRNA, BAPTA chelation of Ca2+ does not prevent azide-induced GLUT1 mRNA induction, demonstrating distinct signaling pathways.\",\n      \"method\": \"BAPTA chelation, ionomycin dose-response, ionomycin vs. azide kinetic comparisons, [Ca2+]i measurements, actinomycin D mRNA decay, Northern blot\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — five lines of experimental evidence with Ca2+ manipulation and mRNA kinetics\",\n      \"pmids\": [\"8772449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Glycogen in 3T3-L1 adipocytes serves as a carbohydrate buffer for GLUT1 glycosylation during glucose deprivation; glycogen-depleted cells show more rapid alteration of GLUT1 glycosylation upon glucose removal, linking cellular glycogen stores to GLUT1 glycosylation fidelity.\",\n      \"method\": \"Glycogen quantification, glycogen depletion experiments, glycoform analysis by Western blot comparing adipocytes vs. CHO cells\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical and cell biological approach, single lab\",\n      \"pmids\": [\"8928771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Both thyroid hormone (T3) and insulin stimulate glucose transport in Clone 9 cells (which express only GLUT1) primarily through activation of plasma membrane-resident GLUT1, not solely by increasing surface GLUT1 abundance, as transport stimulation exceeds the increase in surface GLUT1 detected by biotinylation.\",\n      \"method\": \"Cell surface biotinylation, Western blot of plasma membrane fractions, 3-O-methyl-D-glucose transport assays\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative surface labeling plus functional assay, single lab\",\n      \"pmids\": [\"8972727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GLUT1 and GLUT3 transport dehydroascorbic acid (DHA) with apparent Km values of 1.1 mM and 1.7 mM, respectively; DHA transport is inhibited by glucose analogs and cytochalasin B but not by L-glucose or fructose; GLUT2, GLUT5, and SGLT1 do not transport DHA; none transport ascorbic acid.\",\n      \"method\": \"Xenopus laevis oocyte expression system, radiolabeled sugar uptake, HPLC confirmation of intracellular reduction of DHA to AA, CHO cell overexpression, competition assays with inhibitors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in Xenopus oocytes with multiple orthogonal validations (HPLC, CHO overexpression, inhibitor pharmacology, mutagenesis)\",\n      \"pmids\": [\"9228080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The C-terminal tail of GLUT2 contributes to glucose transport kinetics (Km for 2-deoxyglucose), while the N-terminal region of GLUT1/GLUT2 determines substrate specificity for alternative substrates (fructose, arabinose, streptozotocin); structural domains for substrate specificity are distinct from those governing kinetic function.\",\n      \"method\": \"GLUT1/GLUT2 chimeras and N62Q mutant expressed via recombinant adenovirus in CV-1 cells; 2-deoxyglucose Km/Vmax kinetics; fructose, arabinose, streptozotocin uptake assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — chimeric mutagenesis with functional kinetic analysis, multiple substrate specificity assays\",\n      \"pmids\": [\"9154929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Sp1 binds to the −102/−82 region of the GLUT1 promoter during fetal cardiac development but not during adulthood; Sp1 site mutation abolishes high transcriptional activity in cardiomyocytes; Sp1 is downregulated postnatally in heart and skeletal muscle, establishing Sp1 as a key transcriptional activator of GLUT1 in the perinatal heart.\",\n      \"method\": \"Transient transfection assays (reporter gene), electrophoretic mobility shift assays (EMSA), site-directed mutagenesis of Sp1 binding site, Western blot of Sp1 in heart/muscle development\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — EMSA plus mutagenesis plus reporter assay, mechanistic identification of transcription factor binding site\",\n      \"pmids\": [\"10364200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Fifteen novel heterozygous GLUT1 mutations (including large deletion, missense, nonsense, deletions, insertions, and splice site mutations) cause GLUT1 deficiency syndrome; these mutations correlate with hypoglycorrhachia and reduced erythrocyte glucose transport activity.\",\n      \"method\": \"FISH, PCR, SSCP, DNA sequencing; erythrocyte glucose transport functional assay\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutation identification combined with functional transport assays in a large patient cohort\",\n      \"pmids\": [\"10980529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Overexpression of stomatin reduces basal GLUT1-mediated glucose transport by 35–50% without altering plasma membrane GLUT1 content, through protein–protein interaction; stomatin binds specifically to the C-terminal 42-amino acid segment of GLUT1 but not to its central loop, decreasing intrinsic transporter activity.\",\n      \"method\": \"Stable transfection of stomatin, glucose transport assays, co-immunoprecipitation, GST-fusion protein pulldown with GLUT1 C-terminal and central loop domains, Western blot of plasma membrane fractions\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — co-IP plus GST pulldown domain mapping plus functional transport assay, identifies specific binding region\",\n      \"pmids\": [\"11287341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hyperosmolarity stimulates GLUT1 expression in a biphasic manner: early phase (0–6 h) involves activation of pre-existing plasma membrane GLUT1 without change in GLUT1 mRNA/protein; late phase (12–24 h) involves ~7.5-fold increase in GLUT1 mRNA mediated by both enhanced transcription and mRNA stabilization (t½ increased from 2 to 8 h), requiring a 44-bp proximal promoter element.\",\n      \"method\": \"Glucose transport assays, Northern blot with actinomycin D mRNA half-life measurements, promoter deletion analysis by transient transfection, GLUT1 protein quantification\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mechanistic dissection with promoter mapping, mRNA stability, and functional transport assays\",\n      \"pmids\": [\"11546675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A GLUT1 R126H missense mutation causes autosomal dominant GLUT1 deficiency syndrome; in Xenopus oocyte expression, the mutant shows high membrane expression but significantly reduced Vmax for 3-O-methyl-D-glucose and dehydroascorbic acid transport, demonstrating that R126 is critical for transport function.\",\n      \"method\": \"Xenopus oocyte expression and transport kinetics, SSCP/sequencing of family members, erythrocyte glucose transport, immunoblot\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo expression system with kinetic analysis demonstrates pathogenicity at molecular level\",\n      \"pmids\": [\"11603379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GLUT1 serves as a receptor for both HTLV-1 and HTLV-2; HTLV envelope receptor-binding domains inhibit glucose transport by interacting with GLUT1; HTLV infection is selectively blocked by cytochalasin B, GLUT1 siRNA knockdown, or competing HTLV envelope glycoproteins; ectopic GLUT1 (but not GLUT3) rescues infection in GLUT1-depleted cells.\",\n      \"method\": \"siRNA knockdown, ectopic expression of GLUT1/GLUT3, cytochalasin B inhibition, HTLV infection assays, glucose transport inhibition assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (siRNA, ectopic expression, pharmacological inhibition), specific GLUT1 requirement demonstrated\",\n      \"pmids\": [\"14622599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"N-glycosylation of GLUT1 at its sole N-linked glycosylation site contributes to transporter affinity for glucose: tunicamycin treatment produces a 2–2.5-fold decrease in Km without change in Vmax, and inhibition of N-glycan processing (deoxymannojirimycin, swainsonine) does not affect GLUT1 trafficking or activity in thyroid anaplastic carcinoma cells; O-glycosylation also contributes to transport activity.\",\n      \"method\": \"Tunicamycin, deoxymannojirimycin, swainsonine inhibitor studies; 2-deoxyglucose uptake; Western blot of glycoforms; jacalin lectin binding; benzyl-GalNAc O-glycosylation inhibition\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition of glycosylation steps with functional readout, single lab\",\n      \"pmids\": [\"12667615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Targeted disruption of the promoter and exon 1 of mouse Glut1 in heterozygous mice recapitulates GLUT1 deficiency syndrome: GLUT1+/- mice show epileptiform EEG discharges, impaired motor activity, hypoglycorrhachia, microencephaly, decreased brain glucose uptake (by PET), and 66% reduction of brain GLUT1 protein.\",\n      \"method\": \"Targeted gene disruption, EEG, PET brain glucose uptake, Western blot, behavioral testing\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo haploinsufficiency model with multiple phenotypic readouts, functional brain imaging\",\n      \"pmids\": [\"16497725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A C-terminal PDZ-binding motif in GLUT1 is critical for growth factor-stimulated cell surface localization and protection from lysosomal degradation; disruption of this motif reduces surface GLUT1 and promotes lysosomal targeting; the PDZ-domain protein GIPC binds GLUT1 via this motif and is required for normal GLUT1 surface levels and glucose uptake.\",\n      \"method\": \"PDZ-motif deletion and point mutation, flow cytometry for surface GLUT1, lysosomal inhibitor experiments, co-immunoprecipitation of GIPC-GLUT1, transferrin receptor recycling comparison, glucose uptake assays in GIPC-deficient cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis plus co-IP plus functional trafficking assays, multiple mechanistic readouts\",\n      \"pmids\": [\"19016655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GLUT1 deficiency syndrome-causing mutations in SLC2A1 can produce both loss of glucose transport and a novel cation leak phenotype in erythrocytes (stomatin-deficient cryohydrocytosis), as demonstrated by Xenopus oocyte expression studies of two specific missense mutations.\",\n      \"method\": \"Xenopus oocyte expression, glucose transport assays, cation flux measurements, 3D structural modeling of GLUT1\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in Xenopus oocytes showing dual functional defects\",\n      \"pmids\": [\"21791420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Effector CD4+ T cells (Th1, Th2, Th17) express high surface GLUT1 and are highly glycolytic, while regulatory T cells express low GLUT1 and rely on lipid oxidation; GLUT1 transgenic mice show selective increase in effector T cells; these distinct metabolic programs can be manipulated in vivo to control T cell subset development.\",\n      \"method\": \"Flow cytometry for surface GLUT1, metabolic flux analysis, GLUT1 transgenic mice, AMPK activator treatment in asthma model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model plus metabolic profiling plus pharmacological manipulation\",\n      \"pmids\": [\"21317389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ATM phosphorylates GLUT1 at serine 490 (S490); ATM inhibition decreases surface GLUT1, glucose and DHA transport, and GLUT1 association with GIPC1, while ATM activation (doxorubicin) increases these parameters; S490A mutation phenocopies ATM inhibition and S490D mutation phenocopies ATM activation, establishing S490 as a functional phosphorylation site regulating GLUT1 trafficking.\",\n      \"method\": \"ATM inhibitor (KU55933) and activator (doxorubicin) experiments, S490A/D point mutants, cell surface GLUT1 quantification, 2-deoxyglucose and DHA transport assays, co-immunoprecipitation of GLUT1/GIPC1, ex vivo skeletal muscle transport\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — phospho-mimetic and phospho-null mutagenesis with functional readouts, in vivo confirmation in skeletal muscle\",\n      \"pmids\": [\"23776597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TXNIP suppresses glucose uptake by directly binding to GLUT1 and inducing GLUT1 internalization through clathrin-coated pits; AMPK-dependent phosphorylation of TXNIP leads to its rapid degradation, releasing GLUT1 inhibition and acutely increasing GLUT1-mediated glucose influx; long-term adaptation also involves TXNIP-dependent regulation of GLUT1 mRNA levels.\",\n      \"method\": \"Co-immunoprecipitation of TXNIP-GLUT1, clathrin-coated pit inhibition, AMPK activation/inhibition, TXNIP phosphorylation mutants, glucose uptake assays, GLUT1 surface quantification, mRNA measurements\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding by co-IP, clathrin pathway inhibitor experiments, AMPK-TXNIP phosphorylation mechanistic link, multiple readouts\",\n      \"pmids\": [\"23453806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The SNX27-retromer complex maintains GLUT1 surface levels by recycling internalized GLUT1 from endosomes back to the plasma membrane, preventing lysosomal degradation; SNX27 or retromer suppression reduces surface GLUT1 abundance.\",\n      \"method\": \"Quantitative proteomics of SNX27 interactome, quantification of surface proteome in SNX27/retromer-suppressed cells by quantitative mass spectrometry, direct PDZ domain-VPS26 interaction characterization\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — global quantitative proteomics of interactome combined with surface proteome quantification, mechanistic interaction mapping\",\n      \"pmids\": [\"23563491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The crystal structure of human GLUT1 was determined at 3.2 Å resolution; the protein adopts a canonical major facilitator superfamily fold captured in an inward-open conformation with 12 transmembrane helices; structural comparison with the bacterial homologue XylE enabled mechanistic interpretation of the alternating access transport mechanism and mapping of disease-associated mutations.\",\n      \"method\": \"X-ray crystallography at 3.2 Å resolution, structure-based mutagenesis analysis, structural comparison with XylE\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic resolution crystal structure with functional mutagenesis analysis, foundational structural paper\",\n      \"pmids\": [\"24847886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RdCVF (rod-derived cone viability factor) promotes cone survival by binding to Basigin-1 (BSG1), which then associates with GLUT1, resulting in increased glucose entry into cones and stimulation of aerobic glycolysis; a missense mutation abolishing RdCVF–BSG1 binding prevents glucose uptake stimulation and cone protection.\",\n      \"method\": \"Co-immunoprecipitation of RdCVF-BSG1 and BSG1-GLUT1, glucose uptake assays, RdCVF missense mutant, in vivo retinitis pigmentosa model, cone survival quantification\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP of ternary complex, functional glucose uptake assays, disease mutant validation, in vivo photoreceptor survival readout\",\n      \"pmids\": [\"25957687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Myeloid-specific GLUT1 deletion in mice abolishes glucose uptake and reduces glycolysis and pentose phosphate pathway activity in macrophages; GLUT1-deficient macrophages show reduced phagocytic capacity contributing to unstable atherosclerotic lesion formation in Ldlr-/- mice, while compensatory glutamine and oleate oxidation occurs but maximal respiratory capacity is blunted.\",\n      \"method\": \"Myeloid-specific Slc2a1 conditional knockout, bone marrow-derived macrophage glucose uptake assays, extracellular flux analysis, flow cytometry for activation markers, phagocytosis assays, atherosclerosis model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type specific KO with multiple metabolic and functional readouts, in vivo disease model\",\n      \"pmids\": [\"30659108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RAB21 regulates retromer-mediated recycling of GLUT1/SLC2A1; RAB21 depletion mis-sorts GLUT1 to lysosomes, reduces glucose uptake, and activates AMPK-ULK1 autophagy; RAB21 controls fission of retromer-decorated SNX27-containing endosomal tubules, selectively affecting GLUT1 recycling without overtly disrupting retrograde transport of IGF2R or WLS.\",\n      \"method\": \"RAB21 siRNA/shRNA depletion, GLUT1 subcellular localization by imaging, glucose uptake assays, AMPK-ULK1 pathway analysis, autophagic flux measurement, retromer complex localization, in vivo tumor growth assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic depletion with mechanistic pathway analysis, functional glucose uptake and autophagy readouts, in vivo validation\",\n      \"pmids\": [\"35993307\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC2A1/GLUT1 is a 12-transmembrane-domain major facilitator superfamily uniporter (crystal structure resolved at 3.2 Å in an inward-open conformation) that mediates facilitated diffusion of glucose and dehydroascorbic acid across the plasma membrane; its surface abundance and intrinsic activity are regulated by multiple mechanisms including: TXNIP-induced clathrin-mediated internalization (released by AMPK-dependent TXNIP degradation), retromer/SNX27-RAB21-mediated endosomal recycling, stomatin-mediated inhibition of intrinsic activity via C-terminal interaction, ATM-dependent S490 phosphorylation promoting GIPC1-assisted trafficking to the cell surface, GIPC1 PDZ-binding at the C-terminal motif protecting internalized GLUT1 from lysosomal degradation, and transcriptional activation by Sp1; GLUT1 also acts as the receptor for HTLV-1/2 and is the primary glucose transporter at the blood-brain barrier whose haploinsufficiency causes GLUT1 deficiency syndrome.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SLC2A1 encodes GLUT1, a 12-transmembrane-domain facilitative glucose transporter that mediates basal glucose uptake across cell membranes, with particularly critical function at the blood–brain barrier where it is the predominant transporter in capillary endothelium [PMID:2211679]. GLUT1 transport activity is regulated at multiple levels: intrinsic transporter activity can be acutely stimulated by metabolic stress or hormones independently of changes in surface abundance [PMID:8349608, PMID:8972727]; cell-surface density is controlled by glucose-responsive trafficking [PMID:1520263], RAB21–retromer-mediated recycling versus lysosomal degradation [PMID:35993307], ATM-dependent S490 phosphorylation that promotes GIPC1 association and surface retention [PMID:23776597, PMID:19016655], and N-linked glycosylation required for ER folding via calnexin/calreticulin and efficient plasma membrane targeting [PMID:8662691, PMID:2017192]; while stomatin binds the GLUT1 C-terminal 42-amino-acid domain and inhibits intrinsic activity without altering surface abundance [PMID:11287341]. Transcriptionally, GLUT1 expression is driven by Sp1 binding at the proximal promoter and CDK6-dependent enhancer histone acetylation, and post-transcriptionally by calcium- and hyperosmolarity-induced mRNA stabilization [PMID:10364200, PMID:36048765, PMID:7491913, PMID:11546675]. Haploinsufficiency caused by loss-of-function mutations such as R126H produces GLUT1 deficiency syndrome with impaired brain glucose delivery [PMID:11603379], and GLUT1 also serves as the cellular entry receptor for HTLV-1 and HTLV-2 [PMID:14622599].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Establishing where GLUT1 operates in the brain: quantitative protein and mRNA analysis demonstrated that GLUT1 is essentially the sole glucose transporter at the blood–brain barrier endothelium, explaining how glucose crosses into the CNS.\",\n      \"evidence\": \"Quantitative Western blot with purified GLUT1 standard, cytochalasin B binding, and in situ hybridization in bovine brain\",\n      \"pmids\": [\"2211679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of GLUT1 density at the BBB under pathological conditions was not addressed\", \"Whether GLUT1 BBB expression differs regionally was not resolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Two regulatory modes of GLUT1 were distinguished: acute metabolic stress (oxidative phosphorylation inhibition) stimulates transport 7.5-fold primarily by activating pre-existing plasma membrane transporters rather than recruiting new ones, while N- and O-linked glycosylation are required for proper membrane targeting and full transport activity.\",\n      \"evidence\": \"Surface biotinylation, subcellular fractionation, cytochalasin B binding in Clone 9 cells; tunicamycin and benzyl-GalNAc treatment with transport assays in carcinoma cells\",\n      \"pmids\": [\"8349608\", \"12667615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The molecular basis of intrinsic activity modulation remained unknown\", \"Whether O-glycosylation affects activity directly or indirectly through trafficking was not separated\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Systematic topology mapping confirmed the 12-transmembrane-helix model and identified which intracellular and extracellular loops are functionally critical for transport.\",\n      \"evidence\": \"Glycosylation-reporter scanning mutagenesis with Xenopus oocyte reconstitution and 2-deoxyglucose uptake\",\n      \"pmids\": [\"8051147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structural detail was lacking\", \"Specific residues within critical loops were not individually characterized\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"The ER quality-control mechanism for GLUT1 folding was defined: N-linked glycosylation is required for association with calnexin and calreticulin, linking glycosylation to the protein folding checkpoint that gates ER export; separately, calcium signaling was shown to upregulate GLUT1 mRNA through both transcriptional and post-transcriptional stabilization mechanisms.\",\n      \"evidence\": \"Cell-free translation with co-IP and glycosylation-deficient mutant; nuclear run-on, mRNA half-life, and Ca2+ chelation experiments\",\n      \"pmids\": [\"8662691\", \"7491913\", \"8772449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether calnexin/calreticulin interaction affects transport kinetics beyond folding was not tested\", \"The calcium-responsive cis-elements in GLUT1 mRNA were not mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"GLUT1/GLUT2 chimera analysis separated the structural determinants of substrate specificity from those governing transport kinetics: the N-terminal 87 residues control substrate selectivity while the C-terminal tail modulates Km.\",\n      \"evidence\": \"Chimeric transporter expression in CV-1 cells with multi-substrate uptake kinetics\",\n      \"pmids\": [\"9154929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-level contacts between the N-terminal domain and substrates were not resolved\", \"How glycosylation at Asn45 of GLUT1 (vs Asn62 of GLUT2) differentially affects Km was not determined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Transcriptional regulation of GLUT1 was mapped to Sp1 binding at the proximal promoter (−102/−82), explaining the developmental switch-off of GLUT1 in cardiac and skeletal muscle as Sp1 declines postnatally.\",\n      \"evidence\": \"Promoter-reporter mutagenesis, EMSA, and nuclear run-on in neonatal versus adult cardiomyocytes\",\n      \"pmids\": [\"10364200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other transcription factors cooperating with Sp1 were not identified\", \"Whether Sp1-dependent regulation operates similarly at the BBB was unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Three advances converged: stomatin was identified as a direct negative regulator that binds the GLUT1 C-terminal 42-aa segment and reduces intrinsic activity without affecting surface abundance; R126H was functionally validated as a loss-of-function mutation causing GLUT1 deficiency syndrome by reducing Vmax; and hyperosmolarity was shown to upregulate GLUT1 through both transcription and mRNA stabilization.\",\n      \"evidence\": \"GST pulldown and co-IP with transport assays; Xenopus oocyte reconstitution with kinetic analysis of R126H; mRNA half-life and promoter-reporter assays under hyperosmotic stress\",\n      \"pmids\": [\"11287341\", \"11603379\", \"11546675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stomatin's mechanism of activity inhibition (conformational or allosteric) was not resolved\", \"Whether stomatin loss in sdCHC directly increases GLUT1 activity in erythrocytes was untested at this point\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"GLUT1 was identified as the cell-surface receptor for HTLV-1 and HTLV-2, with viral envelope glycoproteins directly engaging GLUT1 and inhibiting glucose transport, establishing an unexpected non-metabolic function.\",\n      \"evidence\": \"GLUT1 siRNA, ectopic expression rescue, and pharmacological inhibition of glucose transport with HTLV infection assays\",\n      \"pmids\": [\"14622599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific GLUT1 extracellular loop(s) mediating envelope binding were not mapped\", \"Whether HTLV binding alters GLUT1 trafficking was not investigated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The PDZ-binding motif at the GLUT1 C-terminus was shown to recruit the adaptor GIPC, which promotes cytokine-stimulated surface localization and protects GLUT1 from lysosomal degradation upon growth factor withdrawal.\",\n      \"evidence\": \"PDZ-motif mutagenesis, GIPC co-IP and siRNA, flow cytometry for surface GLUT1, lysosomal inhibitor rescue\",\n      \"pmids\": [\"19016655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The vesicular compartment from which GIPC promotes GLUT1 recycling was not identified\", \"Whether GIPC binds GLUT1 directly or within a larger complex was uncertain\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Specific SLC2A1 mutations were shown to cause stomatin-deficient cryohydrocytosis (sdCHC) by producing a dual phenotype — loss of glucose transport and gain of cation leak — linking GLUT1 to erythrocyte cation homeostasis.\",\n      \"evidence\": \"Xenopus oocyte reconstitution with glucose transport and cation flux assays; patient mutation analysis\",\n      \"pmids\": [\"21791420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The structural basis for how mutations convert a glucose channel into a cation leak was modeled but not experimentally proven\", \"The relationship between stomatin loss and cation leak was correlative\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"ATM kinase was identified as a direct upstream regulator: phosphorylation of GLUT1 at S490 promotes GIPC1 association, surface localization, and transport activity, connecting DNA damage signaling to glucose metabolism.\",\n      \"evidence\": \"S490A/S490D phospho-mutants, ATM inhibitor/activator, co-IP of GLUT1–GIPC1, transport assays in cell lines and ex vivo skeletal muscle\",\n      \"pmids\": [\"23776597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ATM directly phosphorylates S490 or acts through an intermediate kinase was not conclusively shown with purified components\", \"Physiological contexts triggering ATM-dependent GLUT1 regulation beyond doxorubicin were not explored\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Conditional myeloid-specific Slc2a1 deletion demonstrated that GLUT1-dependent glucose uptake is essential for macrophage glycolysis, pentose phosphate pathway flux, phagocytic capacity, and proper inflammatory polarization, with in vivo consequences for atherosclerotic plaque stability.\",\n      \"evidence\": \"Myeloid-specific Cre-driven Slc2a1 KO; Seahorse extracellular flux analysis, metabolomics, phagocytosis assay, Ldlr atherosclerosis model\",\n      \"pmids\": [\"30659108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether compensatory upregulation of other SLC2A family members occurs in GLUT1-null macrophages was not fully resolved\", \"The specific metabolic bottleneck causing phagocytic failure was not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Two studies established new layers of GLUT1 regulation: CDK6 maintains active histone marks (H3K27ac, H4K8ac, H3K4me1) at the SLC2A1 enhancer to drive transcription, while RAB21 GTPase directs retromer-mediated recycling of GLUT1 from endosomes to the plasma membrane, with RAB21 loss mis-sorting GLUT1 to lysosomes and activating compensatory autophagy.\",\n      \"evidence\": \"ChIP for histone marks at SLC2A1 enhancer with CDK6 manipulation; RAB21 siRNA/KO with GLUT1 localization, retromer co-IP, glucose uptake, and autophagy flux in vitro and in xenograft models\",\n      \"pmids\": [\"36048765\", \"35993307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CDK6 kinase activity or a scaffolding function maintains the enhancer marks is not distinguished\", \"The cargo-recognition mechanism by which RAB21-retromer selects GLUT1 over other cargoes is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis by which stomatin inhibits intrinsic GLUT1 activity, how GLUT1 transitions between inward- and outward-facing conformations during catalytic cycling in the context of its regulatory partners, and the full inventory of kinases and phosphosites governing GLUT1 trafficking in different cell types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstituted system has measured how stomatin binding alters GLUT1 conformational dynamics\", \"Comprehensive phosphoproteomics of GLUT1 across tissues has not been reported\", \"The interplay between glycosylation, phosphorylation, and protein–protein interactions in combinatorial regulation of GLUT1 is not integrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 4, 8, 9, 13, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 5, 6, 8, 14, 15, 16, 17]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 4, 8, 9, 13, 16, 18]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [17, 22]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [5, 6, 15, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"STOM\",\n      \"GIPC1\",\n      \"CANX\",\n      \"CALR\",\n      \"RAB21\",\n      \"CDK6\",\n      \"ATM\",\n      \"SP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SLC2A1 (GLUT1) is a ubiquitously expressed, 12-transmembrane-domain facilitated glucose uniporter of the major facilitator superfamily that mediates basal glucose uptake across the plasma membrane and also transports dehydroascorbic acid [PMID:3839598, PMID:24847886, PMID:9228080]. Its surface abundance is dynamically regulated by TXNIP-driven clathrin-mediated internalization (relieved by AMPK-dependent TXNIP degradation), SNX27–retromer–RAB21-mediated endosomal recycling back to the plasma membrane, and GIPC1 binding to a C-terminal PDZ motif that protects internalized GLUT1 from lysosomal degradation; ATM phosphorylation of Ser490 promotes GIPC1 association and surface retention, while stomatin binding to the C-terminal tail inhibits intrinsic transport activity without altering surface levels [PMID:23453806, PMID:23563491, PMID:35993307, PMID:19016655, PMID:23776597, PMID:11287341]. GLUT1 is the predominant glucose transporter at the blood–brain barrier and in erythrocytes, and heterozygous loss-of-function mutations cause GLUT1 deficiency syndrome, characterized by hypoglycorrhachia, seizures, and developmental delay [PMID:2211679, PMID:1714544, PMID:10980529]. GLUT1 also serves as the obligate receptor for HTLV-1 and HTLV-2 entry, and its differential expression programs distinct metabolic fates in effector versus regulatory T cells [PMID:14622599, PMID:21317389].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Determination of the full primary structure of human GLUT1 from cDNA sequencing established the protein as a ~500 amino acid, 12-transmembrane-domain transporter, providing the molecular framework for all subsequent functional studies.\",\n      \"evidence\": \"cDNA cloning/sequencing with biochemical validation of purified erythrocyte transporter\",\n      \"pmids\": [\"3839598\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No three-dimensional structure available\", \"Transport mechanism inferred from topology only\", \"Post-translational regulation unknown\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Quantitative protein and ligand-binding analyses demonstrated that GLUT1 accounts for essentially all glucose transporter activity at the blood–brain barrier, establishing its physiological centrality for cerebral glucose supply.\",\n      \"evidence\": \"Quantitative Western blotting, [3H]cytochalasin B binding, and in situ hybridization on bovine brain cortex\",\n      \"pmids\": [\"2211679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of other GLUT isoforms under pathological conditions not addressed\", \"Human BBB confirmation needed\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Clinical and functional characterization of patients with persistent hypoglycorrhachia, seizures, and developmental delay linked these phenotypes to defective erythrocyte glucose transport, defining GLUT1 deficiency syndrome as a haploinsufficiency disorder.\",\n      \"evidence\": \"Clinical phenotyping combined with erythrocyte glucose transport assays and CSF glucose measurements\",\n      \"pmids\": [\"1714544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causative mutations not yet molecularly identified at the DNA level in this initial report\", \"Genotype–phenotype correlations not established\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Discovery that glucose deprivation redistributes GLUT1 from intracellular pools to the plasma membrane, and that GLUT1 mRNA is stress-inducible (like GRP-78), established that GLUT1 surface abundance and expression are dynamically regulated by metabolic stress rather than being constitutive.\",\n      \"evidence\": \"Subcellular fractionation, immunofluorescence, Northern blots under glucose deprivation, calcium ionophore, tunicamycin, and reductant stress in multiple cell lines\",\n      \"pmids\": [\"1706526\", \"2017192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathways mediating stress-induced translocation unknown\", \"Whether intrinsic activity also changes during stress not resolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Glycosylation scanning mutagenesis in Xenopus oocytes experimentally verified the 12-transmembrane-helix topology with cytoplasmic N- and C-termini and a large central cytoplasmic loop, resolving the membrane orientation predicted from the sequence.\",\n      \"evidence\": \"Systematic glycosylation site insertion mutagenesis in Xenopus oocytes and reticulocyte lysate with 2-deoxyglucose uptake readout\",\n      \"pmids\": [\"8051147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure\", \"Helix packing and substrate translocation path unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Inhibition of oxidative phosphorylation was shown to stimulate glucose transport primarily by activating pre-existing plasma membrane GLUT1 rather than recruiting intracellular transporters, revealing that intrinsic transporter activity is a regulated parameter distinct from surface abundance.\",\n      \"evidence\": \"Four orthogonal approaches (immunofluorescence, differential centrifugation, surface biotinylation, cytochalasin B binding) in Clone 9 cells treated with azide\",\n      \"pmids\": [\"8349608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of intrinsic activity modulation unknown\", \"Kinase or signaling intermediate responsible not identified\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Reconstitution in Xenopus oocytes demonstrated that GLUT1 transports dehydroascorbic acid (Km ~1.1 mM) via the same pathway as glucose, expanding the substrate repertoire beyond hexoses and establishing GLUT1 as the molecular basis for cellular vitamin C acquisition via its oxidized form.\",\n      \"evidence\": \"Xenopus oocyte expression, radiolabeled uptake, HPLC product identification, CHO overexpression, inhibitor competition\",\n      \"pmids\": [\"9228080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for DHA recognition versus glucose not defined\", \"Physiological relevance of DHA transport versus sodium-dependent ascorbate transporters not quantified in vivo\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of Sp1 binding to the −102/−82 promoter element, with postnatal Sp1 downregulation in heart, provided the first transcription-factor-level explanation for the developmental switch from high to low GLUT1 expression in cardiac and skeletal muscle.\",\n      \"evidence\": \"EMSA, site-directed mutagenesis of Sp1 site, reporter assays, Western blot of Sp1 during heart development\",\n      \"pmids\": [\"10364200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other transcription factors contributing to developmental regulation not mapped\", \"Mechanism of postnatal Sp1 downregulation unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Stomatin was identified as a direct negative regulator of GLUT1 intrinsic activity that binds the C-terminal 42-amino-acid segment without altering surface expression, providing a molecular mechanism for modulation of transport kinetics independent of trafficking.\",\n      \"evidence\": \"Co-immunoprecipitation, GST pulldown domain mapping, functional glucose transport in stomatin-overexpressing cells\",\n      \"pmids\": [\"11287341\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural basis of the stomatin–GLUT1 interaction unknown\", \"Physiological contexts where stomatin regulation is rate-limiting not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"GLUT1 was established as the receptor for HTLV-1 and HTLV-2 through siRNA knockdown, ectopic rescue, and pharmacological inhibition, linking glucose transporter biology to retroviral entry and explaining HTLV tropism.\",\n      \"evidence\": \"siRNA knockdown, GLUT1/GLUT3 ectopic expression, cytochalasin B inhibition, HTLV infection assays\",\n      \"pmids\": [\"14622599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural interface between HTLV envelope and GLUT1 not defined\", \"Whether HTLV binding alters glucose transport in infected cells in vivo not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that a C-terminal PDZ-binding motif recruits GIPC1 to protect internalized GLUT1 from lysosomal degradation, and that disruption of this motif reduces surface GLUT1, established the first post-endocytic sorting mechanism controlling GLUT1 fate.\",\n      \"evidence\": \"PDZ motif deletion/mutation, co-immunoprecipitation of GIPC–GLUT1, surface GLUT1 quantification, lysosomal inhibitor rescue, glucose uptake in GIPC-deficient cells\",\n      \"pmids\": [\"19016655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling GIPC–GLUT1 interaction not defined\", \"Relationship to retromer-mediated recycling not yet established\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Three converging studies defined the GLUT1 surface-abundance regulatory circuit: TXNIP directly binds GLUT1 and promotes clathrin-mediated internalization (relieved by AMPK-dependent TXNIP phosphorylation/degradation); ATM phosphorylates GLUT1-S490 to promote GIPC1 binding and surface retention; and SNX27–retromer recycles internalized GLUT1 from endosomes, preventing lysosomal degradation.\",\n      \"evidence\": \"Co-IP of TXNIP–GLUT1 with clathrin inhibitor experiments, AMPK-TXNIP phospho-mutants, ATM inhibitor/activator with S490A/D mutants and ex vivo muscle, quantitative proteomics of SNX27 interactome and surface proteome in retromer-depleted cells\",\n      \"pmids\": [\"23453806\", \"23776597\", \"23563491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative quantitative contribution of each pathway to steady-state GLUT1 surface levels unknown\", \"Whether TXNIP, ATM, and SNX27–retromer act in series or in parallel not resolved\", \"Structural basis of TXNIP–GLUT1 interaction not determined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The 3.2 Å crystal structure of human GLUT1 in an inward-open conformation revealed the canonical MFS fold and enabled structural mapping of disease-causing mutations onto the transport pathway, providing the atomic framework for understanding alternating-access transport and pathogenic mechanism.\",\n      \"evidence\": \"X-ray crystallography at 3.2 Å, structural comparison with bacterial homologue XylE, mutation mapping\",\n      \"pmids\": [\"24847886\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Outward-open and occluded conformations not captured\", \"Dynamics of the alternating-access cycle not resolved\", \"No structure with bound glucose substrate\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Myeloid-specific GLUT1 deletion demonstrated that GLUT1 is essential for macrophage glucose uptake, glycolysis, pentose phosphate pathway activity, and phagocytic capacity, directly linking GLUT1-dependent metabolism to innate immune function and atherosclerotic plaque stability.\",\n      \"evidence\": \"Conditional Slc2a1 knockout in myeloid cells, metabolic flux analysis, phagocytosis assays, Ldlr−/− atherosclerosis model\",\n      \"pmids\": [\"30659108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GLUT3 or other transporters can compensate over longer time frames not tested\", \"Contribution of GLUT1-dependent glycolysis to other macrophage effector functions (cytokine secretion, antigen presentation) not fully explored\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"RAB21 was identified as the GTPase controlling fission of SNX27–retromer-decorated endosomal tubules for GLUT1 recycling; RAB21 depletion diverts GLUT1 to lysosomes, reduces glucose uptake, and triggers AMPK–ULK1 autophagy, closing the loop between endosomal sorting and metabolic signaling.\",\n      \"evidence\": \"RAB21 siRNA/shRNA, GLUT1 subcellular imaging, glucose uptake assays, AMPK-ULK1 pathway analysis, in vivo tumor growth\",\n      \"pmids\": [\"35993307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RAB21 directly contacts GLUT1 or acts only on the retromer tubule not determined\", \"GEF and GAP for RAB21 in this context not identified\", \"Integration with TXNIP- and ATM-dependent regulation not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A complete structural view of the GLUT1 transport cycle (outward-open, occluded, substrate-bound states), the quantitative integration of TXNIP, ATM–GIPC1, and SNX27–retromer–RAB21 trafficking arms into a unified regulatory model, and the structural basis of the stomatin inhibitory interaction remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No outward-open or occluded-state human GLUT1 structure\", \"Relative flux contributions of each trafficking pathway to surface GLUT1 not quantified in any single system\", \"Structural basis of stomatin-mediated intrinsic activity inhibition unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 7, 9, 17, 23, 33, 35]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 6, 7, 16, 27, 31, 32]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [32, 36]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 7, 9, 17, 33, 35]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [27, 31, 32, 36]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [36]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [29, 35]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 20, 24, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TXNIP\",\n      \"GIPC1\",\n      \"SNX27\",\n      \"RAB21\",\n      \"stomatin\",\n      \"BSG\",\n      \"calnexin\",\n      \"calreticulin\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}